Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Mar. 01, 2022 | Jun. 30, 2021 | |
Cover [Abstract] | |||
Entity Registrant Name | AWARE INC /MA/ | ||
Entity Central Index Key | 0001015739 | ||
Trading Symbol | AWRE | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Common Stock, Shares Outstanding | 21,642,260 | ||
Entity Public Float | $ 50,128,551 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2021 | ||
Amendment Flag | false | ||
Document Fiscal Year Focus | 2021 | ||
Document Fiscal Period Focus | FY | ||
ICFR Auditor Attestation Flag | false | ||
Entity Shell Company | false | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Interactive Data Current | Yes | ||
Title of 12(b) Security | Common Stock, $0.01 par value per share | ||
Security Exchange Name | NASDAQ | ||
Entity File Number | 000-21129 | ||
Entity Incorporation, State or Country Code | MA | ||
Entity Tax Identification Number | 04-2911026 | ||
Entity Address, Address Line One | 40 Middlesex Turnpike | ||
Entity Address, City or Town | Bedford | ||
Entity Address, State or Province | MA | ||
Entity Address, Postal Zip Code | 01730 | ||
City Area Code | 781 | ||
Local Phone Number | 276-4000 | ||
Document Annual Report | true | ||
Auditor Name | RSM US LLP | ||
Auditor Location | Boston, Massachusetts | ||
Auditor Firm ID | 49 | ||
Document Transition Report | false | ||
Documents Incorporated by Reference | DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s definitive Proxy Statement to be delivered to shareholders in connection with the registrant’s Annual Meeting of Shareholders to be held on June 15, 2022 are incorporated by reference into Part III of this Annual Report on Form 10-K. |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Current assets: | ||
Cash and cash equivalents | $ 29,963 | $ 38,565 |
Accounts receivable (less allowance for doubtful accounts of $74 at December 31, 2021 and $138 at December 31, 2020) | 3,763 | 2,285 |
Unbilled receivables | 3,087 | 2,229 |
Tax receivable | 1,411 | 0 |
Prepaid expenses and other current assets | 591 | 582 |
Total current assets | 38,815 | 43,661 |
Property and equipment, net | 3,216 | 3,701 |
Intangible assets, net | 3,222 | 1,217 |
Goodwill | 3,120 | 1,651 |
Long term tax receivable | 0 | 1,398 |
Total assets | 48,373 | 51,628 |
Current liabilities: | ||
Accounts payable | 283 | 494 |
Accrued expenses | 1,909 | 1,531 |
Deferred revenue | 3,549 | 3,843 |
Total current liabilities | 5,741 | 5,868 |
Long-term deferred revenue | 191 | 90 |
Long-term contingent acquisition payment | 919 | 0 |
Total long-term liabilities | 1,110 | 90 |
Commitments and contingent liabilities (Note 7) | 0 | 0 |
Stockholders’ equity: | ||
Preferred stock, $1.00 par value; 1,000,000 shares authorized, none outstanding | 0 | 0 |
Common stock, $.01 par value; shares authorized, 70,000,000 in 2021 and 2020; issued and outstanding of 21,613,982 as of December 31, 2021 and 21,378,833 as of December 31, 2020 | 216 | 214 |
Additional paid-in capital | 97,778 | 96,104 |
Accumulated deficit | (56,472) | (50,648) |
Total stockholders’ equity | 41,522 | 45,670 |
Total liabilities and stockholders’ equity | $ 48,373 | $ 51,628 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Statement Of Financial Position [Abstract] | ||
Allowance for doubtful accounts (in dollars) | $ 74 | $ 138 |
Preferred stock, par value (in dollars per share) | $ 1 | $ 1 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 70,000,000 | 70,000,000 |
Common stock, shares issued | 21,613,982 | 21,378,833 |
Common stock, shares outstanding | 21,613,982 | 21,378,833 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Revenue: | ||
Total revenue | $ 16,854 | $ 11,309 |
Costs and expenses: | ||
Cost of services and other | 1,210 | 810 |
Research and development | 9,259 | 9,093 |
Selling and marketing | 6,324 | 5,411 |
General and administrative | 6,158 | 5,419 |
Total costs and expenses | 22,951 | 20,733 |
Operating loss | (6,097) | (9,424) |
Interest and other income | 4 | 176 |
Loss before benefit for income taxes | (6,093) | (9,248) |
Benefit for income taxes | (269) | (1,634) |
Net loss | $ (5,824) | $ (7,614) |
Net loss per share – basic | $ (0.27) | $ (0.35) |
Net loss per share – diluted | $ (0.27) | $ (0.35) |
Weighted-average shares - basic | 21,525 | 21,473 |
Weighted-average shares - diluted | 21,525 | 21,473 |
Software licenses | ||
Revenue: | ||
Total revenue | $ 7,973 | $ 5,038 |
Software maintenance | ||
Revenue: | ||
Total revenue | 6,679 | 5,429 |
Services and other | ||
Revenue: | ||
Total revenue | $ 2,202 | $ 842 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Cash flows from operating activities: | ||
Net loss | $ (5,824) | $ (7,614) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 687 | 561 |
Stock-based compensation | 1,567 | 838 |
Deferred taxes | (269) | |
Bad debt provision | (64) | 118 |
Increase (decrease) from changes in assets and liabilities: | ||
Accounts receivable | (1,410) | 84 |
Unbilled receivables | (837) | 1,086 |
Prepaid expenses and other current assets | (9) | (171) |
Tax receivable | (13) | (1,398) |
Accounts payable | (249) | 307 |
Accrued expenses | 380 | 435 |
Deferred revenue | (193) | 480 |
Net cash used in operating activities | (6,234) | (5,274) |
Cash flows from investing activities: | ||
Purchases of property and equipment | (27) | (484) |
Cash paid for acquisitions, net | (2,450) | (2,430) |
Net cash used in investing activities | (2,477) | (2,914) |
Cash flows from financing activities: | ||
Proceeds from issuance of common stock | 163 | 50 |
Payments made for taxes of employees who surrendered shares related to unrestricted stock | (54) | (93) |
Repurchase of common stock | (946) | |
Net cash provided by (used in) financing activities | 109 | (989) |
Decrease in cash and cash equivalents | (8,602) | (9,177) |
Cash and cash equivalents, beginning of year | 38,565 | 47,742 |
Cash and cash equivalents, end of year | $ 29,963 | $ 38,565 |
CONSOLIDATED STATEMENTS OF STOC
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-In Capital | Accumulated Deficit |
Balance at Dec. 31, 2019 | $ 53,435 | $ 214 | $ 96,255 | $ (43,034) |
Balance (in shares) at Dec. 31, 2019 | 21,443,000 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Issuance of unrestricted stock | $ 2 | (2) | ||
Issuance of unrestricted stock (in shares) | 246,000 | |||
Shares surrendered by employees to pay taxes related to unrestricted stock | (93) | (93) | ||
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares) | (27,000) | |||
Issuance of common stock under employee stock purchase plan | 50 | 50 | ||
Issuance of common stock under employee stock purchase plan (in shares) | 15,000 | |||
Stock-based compensation expense | 838 | 838 | ||
Repurchase of common stock | (946) | $ (2) | (944) | |
Repurchase of common stock (in shares) | (298,000) | |||
Net loss | (7,614) | (7,614) | ||
Balance at Dec. 31, 2020 | $ 45,670 | $ 214 | 96,104 | (50,648) |
Balance (in shares) at Dec. 31, 2020 | 21,378,833 | 21,379,000 | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Issuance of unrestricted stock | $ 2 | (2) | ||
Issuance of unrestricted stock (in shares) | 189,000 | |||
Shares surrendered by employees to pay taxes related to unrestricted stock | $ (54) | (54) | ||
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares) | (16,000) | |||
Issuance of common stock under employee stock purchase plan | 163 | 163 | ||
Issuance of common stock under employee stock purchase plan (in shares) | 62,000 | |||
Stock-based compensation expense | 1,567 | 1,567 | ||
Net loss | (5,824) | (5,824) | ||
Balance at Dec. 31, 2021 | $ 41,522 | $ 216 | $ 97,778 | $ (56,472) |
Balance (in shares) at Dec. 31, 2021 | 21,613,982 | 21,614,000 |
Nature of Business
Nature of Business | 12 Months Ended |
Dec. 31, 2021 | |
Organization Consolidation And Presentation Of Financial Statements [Abstract] | |
Nature of Business | 1 NATURE OF BUSINESS We are a global leader in biometrics software offerings and solutions. Our portfolio enables government agencies and commercial entities to enroll, identify authenticate and enable using biometrics, which comprise physiological characteristics, such as fingerprints, faces, irises and voices. • Enroll: Register biometric identities into an organization’s secure database • Identify: Utilize an organization’s secure database to accurately identify individuals using biometric data • Authenticate: Provide frictionless multi-factor, passwordless access to secured accounts and databases with biometric verification • Enable: Manage the lifecycle of secure identities through optimized biometric interchanges We have been engaged in this business since 1993. Our comprehensive portfolio of biometric solutions is based on innovative, robust products designed explicitly for ease of integration, including customer-managed and integration ready biometric frameworks, platforms, software development kits (“SDKs”) and services. Principal government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Principal commercial applications include mobile enrollment, user authentication, identity proofing, and secure transaction enablement. Our products span multiple biometric modalities including fingerprint, face, iris and voice, and provide interoperable, standards-compliant, field-proven biometric functionality. Our products are used to capture, verify, format, compress and decompress biometric images as well as aggregate, analyze, process, match and transport those images and templates within biometric systems. For large deployments, we may provide project management and software engineering services. We sell our biometrics software products and services globally through a multifaceted distribution strategy using systems integrators, original equipment manufacturers (“OEMs”), VARs, partners, and directly to end user customers. Certain amounts in the consolidated financial statements and associated notes may not add due to rounding. All percentages have been calculated using unrounded amounts. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation - The consolidated financial statements include the accounts of Aware, Inc. and its subsidiaries (“the Company”). All significant intercompany transactions have been eliminated. Use of Estimates – The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of acquired assets and assumed liabilities in business combinations, earn-out liability, goodwill and long-lived asset impairment and valuation allowance for deferred income tax assets. Actual results could differ from those estimates. Fair Value Measurements - The Financial Accounting Standards Board (“FASB”) Codification defines fair value and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable. Cash and cash equivalents, which primarily include money market mutual funds, were $30.0 million and $38.6 million at December 31, 2021 and 2020, respectively. We classified our cash equivalents of $29.0 million and $37.9 million as of December 31, 2021 and 2020, respectively, within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Our cash equivalents are measured at fair value on a recurring basis and their carrying values approximate their respective fair values. As of December 31, 2021, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2021 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Assets: Money market funds (included in cash and cash equivalents) $ 28,952 $ - $ - Total assets $ 28,952 $ - $ - Liabilities: Contingent acquisition payment $ - $ - $ 919 Total liabilities $ - $ - $ 919 The fair value of our contingent acquisition payment was determined using a Monte Carlo simulation and there was no change in fair value from the initial recording date (acquisition date) to December 31, 2021 due to the proximity of the acquisition to year-end. As of December 31, 2020, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 37,948 $ - $ - Total $ 37,948 $ - $ - Cash and Cash Equivalents – Cash and cash equivalents, which consist primarily of money market funds and demand deposits, are stated at fair value. All highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Our cash balances exceed the Federal Deposit Insurance Corporation limits. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents. Allowance for Doubtful Accounts – Accounts are charged to the allowance for doubtful accounts as they are deemed uncollectible based on a periodic review of the accounts. For the years ended December 31, 2021 and 2020, changes to and ending balances of the allowance for doubtful accounts were as follows (in thousands): Years ended December 31, 2021 2020 Allowance for doubtful accounts balance - beginning of year $ 138 $ 20 Additions to the allowance for doubtful accounts - 118 Deductions against the allowance for doubtful accounts (64 ) - Allowance for doubtful accounts balance - end of year $ 74 $ 138 Property and Equipment – Property and equipment is stated at cost. Depreciation and amortization of property and equipment is provided using the straight-line method over the estimated useful lives of the assets. Upon retirement or sale, the costs of the assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss on disposal is included in the determination of income or loss. Expenditures for repairs and maintenance are charged to expense as incurred. The estimated useful lives of assets are: Building 30 years Building improvements 5 to 20 years Furniture and fixtures 5 years Computer and office equipment 3 years Purchased software 3 years Goodwill – We record goodwill when consideration paid in a business acquisition exceeds the value of the net assets acquired. Our estimates of fair value are based upon assumptions believed to be reasonable at the time, but such estimates are inherently uncertain and unpredictable. Assumptions may be incomplete or inaccurate and unanticipated events or circumstances may occur, which may affect the accuracy of validity of such assumptions, estimates or actual results. Goodwill is not amortized but rather is tested for impairment annually in the fourth quarter or more frequently, if facts and circumstances warrant a review. Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, or unanticipated competition. We have determined that there is a single reporting unit for the purpose of conducting the goodwill impairment assessment. In accordance with ASC Topic 350, Intangibles—Goodwill and Other, we first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If after assessing the totality of events or circumstances, we determine that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of the reporting unit is less than its carrying amount, then the quantitative test is required. The quantitative goodwill impairment test requires us to estimate and compare the fair value of the reporting unit, determined using an income approach and a market approach, with its carrying value. If the fair value of the reporting unit exceeds the carrying value of the net assets, goodwill is not impaired. If the fair value of the reporting unit is less than the carrying value, the difference is recorded as an impairment loss up to the amount of goodwill. Application of the goodwill impairment test requires judgments, including identification of the reporting units, assigning goodwill to reporting units, a qualitative assessment to determine whether there are any impairment indicators, and determining the fair value of each reporting unit which often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, asset lives and market multiples, among other items. There is no assurance that the actual future earnings or cash flows of the reporting unit will not decline significantly from the projections used in the impairment analysis. Goodwill impairment charges may be recognized in future periods to the extent changes in factors or circumstances occur, including deterioration in the macroeconomic environment and industry, deterioration in the Company’s performance or its future projections, or changes in plans for its reporting unit. The changes in goodwill for the years ended December 31, 2021 and 2020 were as follows (in thousands): As of December 31, 2021 and 2020, we had $3.1 and $1.7 million of goodwill, respectively. Changes in the valuation of goodwill could materially impact our operating results and financial position. We performed a quantitative analysis during the year ended December 31, 2021 and determined there was no impairment loss and to date, there have been no impairments of goodwill. Goodwill Balance as of December 31, 2019 $ — Goodwill arising from AFIX acquisition 1,651 Balance as of December 31, 2020 1,651 Goodwill arising from FortressID acquisition 1,469 Balance as of December 31, 2021 $ 3,120 Valuation of Long-Lived Assets – We review long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If an impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to identify the potential impairment reflect our best estimates using appropriate assumptions and projections at that time. In evaluating potential impairment of these assets, we specifically consider whether any indicators of impairment are present, including, but not limited to: • whether there has been a significant adverse change in the business climate that affects the value of an asset: • whether there has been a significant change in the extent or way an asset is used; and • whether there is an expectation that the asset will be sold or disposed of before the end of its originally estimated useful life. We did not identify any events or changes in business circumstances that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate during the years ended December 31, 2021 and 2020. Revenue recognition . The core principle of Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”) is that we should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To achieve that core principle, we apply the following five step model: 1) Identify the contract with the customer A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the related payment terms, (ii) the contract has commercial substance, and (iii) we determine that collection of substantially all consideration for goods and services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s intent and ability to pay, which is based on a variety of factors including the customer’s historical payment experience, or in the case of a new customer, published credit and financial information pertaining to the customer. We evaluate contract modifications for the impact on revenue recognition if they have been approved by both parties such that the enforceable rights and obligations under the contract have changed. Contract modifications are either accounted for using a cumulative effect adjustment or prospectively over the remaining term of the arrangement. The determination of which method is more appropriate depends on the nature of the modification, which we evaluate on a case-by-case basis. We combine two or more contracts entered into at or near the same time with the same customer and account for them as a single contract if (i) the contracts are negotiated as a package with a common commercial objective, (ii) the amount of consideration to be paid in one contract depends on the price or performance of the other contract, or (iii) some or all of the goods or services in one contract would be combined with some or all of the goods and services in the other contract into a single performance obligation. If two or more contracts are combined, the consideration to be paid is aggregated and allocated to the individual performance obligations without regard to the consideration specified in the individual contracts. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the goods and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the good or service either on its own or together with other available resources, and are distinct in the context of the contract, whereby the transfer of the good or service is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods and services, we apply judgment to determine whether promised goods and services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods and services are accounted for as a combined performance obligation. To identify performance obligations, we consider all of the goods or services promised in a contract regardless of whether they are explicitly stated or are implied by customary business practices. 3) Determine the transaction price The transaction price is determined based on the consideration we expect to be entitled in exchange for transferring promised goods and services to the customer. Determining the transaction price requires significant judgment. To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur. Any estimates, including the effect of the constraint on variable consideration, are evaluated at each reporting period. Some of our arrangements include usage-based royalties where a software license is the predominant item that the royalty relates to. In these arrangements, revenue from the usage-based royalty is recognized when the subsequent usage occurs. The amount of consideration is not adjusted for a significant financing component if the time between payment and the transfer of the related good or service is expected to be one year or less under the practical expedient in ASC 606-10-32-18. Our revenue arrangements are typically accounted for under such expedient, as payment is typically due within 30 to 60 days. As of December 31, 2021 and 2020, none of our contracts contained a significant financing component. Our arrangements can include variable fees, such as the option to purchase additional usage of a previously delivered software license. The Company may also provide pricing concessions to clients, a business practice that also gives rise to variable fees in contracts. The Company also reviews contractual termination provisions in determining contractual term and total transaction price. For variable fees arising from the client’s purchase of additional usage of a previously delivered software license, we apply the sales and usage-based royalties guidance related to a license of intellectual property and recognizes the revenue in the period the underlying sale or usage occurs. We include variable fees in the determination of total transaction price if it is not probable that a future significant reversal of revenue will occur. We use the expected value or most likely value amount, whichever is more appropriate for specific circumstances, to estimate variable consideration, and the estimates are based on the level of historical price concessions offered to clients. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP”) basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The consideration to be received is allocated among the separate performance obligations based on relative SSPs. The SSP is the price at which we would sell a promised good or service separately to a customer. The best estimate of SSP is the observable price of a good or service when we sell that good or service separately. A contractually stated price or a list price for a good or service may be the SSP of that good or service. We use a range of amounts to estimate SSP when we sell each of the goods and services separately and need to determine whether there is a discount that needs to be allocated based on the relative SSP of the various goods and services. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, we typically determine the SSP using an adjusted market assessment approach using information that may include market conditions and other observable inputs. We typically have more than one SSP for individual goods and services due to the stratification of those goods and services by customers and circumstances. In these instances, we may use information such as the nature of the customer and distribution channel in determining the SSP. 5) Recognize revenue when or as we satisfy a performance obligation We satisfy performance obligations either over time or at a point in time. Revenue is recognized over time if 1) the customer simultaneously receives and consumes the benefits provided by our performance, 2) our performance creates or enhances an asset that the customer controls as the asset is created or enhanced, or 3) our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date. If we do not satisfy a performance obligation over time, the related performance obligation is satisfied at a point in time by transferring the control of a promised good or service to a customer. We categorize revenue as software licenses, software maintenance, or services and other. Specific revenue recognition policies apply to each category of revenue. Software licenses Software licenses consist of revenue from the sale of software licenses for biometrics and imaging applications. Our software licenses are functional intellectual property and typically provide customers with the right to use our software on a term or perpetual basis as it exists when made available to the customer. We recognize revenue from perpetual software licenses at a point in time upon delivery, provided all other revenue recognition criteria are met. We also offer certain products pursuant to a subscription-based software model which includes a term software license to use the software for a fixed term. We recognize revenue for fixed fees associated with subscription-based software licenses at a point in time upon delivery, provided all other revenue recognition criteria are met. Fees subject to the usage-based royalty exception are recognized when the subsequent usage occurs. Also, with our acquisition of FortressID and adaption of our current products to be delivered in a hosted environment with AwareID, we expect to recognize revenue from our SaaS offerings in future periods. SaaS offerings are recognized ratably over the subscription period. For the year ended December 31, 2021 we did not generate revenue from SaaS contracts. Software maintenance Software maintenance consists of revenue from the sale of software maintenance contracts for biometrics and imaging software. Software maintenance contracts entitle customers to receive software support and software updates, if and when they become available, during the term of the maintenance contract. Software support and software updates are considered distinct services. However, these distinct services are considered a single performance obligation consisting of a series of distinct services that are substantially the same and have the same pattern of transfer to the customer. We recognize software maintenance revenue over time on a straight-line basis over the contract period. Services Service revenue consists of fees from biometrics customers for software engineering services. We recognize services revenue over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted), provided all other revenue recognition criteria are met. The use of the over-time revenue recognition method requires judgment in developing budgeted labor hours. Changes in budgeted hours may occur and the resulting impact on revenue recognition is accounted for in the period of the change in estimate. Arrangements with multiple performance obligations In addition to selling software licenses, software maintenance and software services on a standalone basis, a significant portion of our contracts include multiple performance obligations. The various combinations of multiple performance obligations and our revenue recognition for each are described as follows: • Perpetual software licenses and software maintenance: When software licenses and software maintenance contracts are sold together, the software licenses and software maintenance are generally considered distinct performance obligations. The transaction price is allocated to the software licenses and the software maintenance based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Revenue allocated to the software maintenance is recognized over time on a straight-line basis over the contract period. • Perpetual software licenses and services: When software licenses and significant customization engineering services are sold together, they are accounted for as a combined performance obligation, as the software licenses are generally highly dependent on, and interrelated with, the associated services and therefore are not distinct performance obligations. Revenue for the combined performance obligation is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). When software licenses and standard implementation or consulting-type services are sold together, they are generally considered distinct performance obligations, as the software licenses are not dependent on or interrelated with the associated services. The transaction price in these arrangements is allocated to the software licenses and services based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Revenue allocated to the services is recognized over time using an input method. In arrangements with both software licenses and services, the software license portion of the arrangement is classified as software license revenue and the services portion is classified as services revenue in our consolidated statements of operations. • Perpetual software licenses, software maintenance and services: When we sell software licenses, software maintenance and software services together, we account for the individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery. Revenue allocated to the services is recognized over time using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). Revenue for the software maintenance is recognized over time on a straight-line basis over the contract period. However, if the software services are significant customization engineering services, they are accounted for with the software licenses as a combined performance obligation, as stated above. Revenue for the combined performance obligation is recognized over time using an input method. • Perpetual software licenses, hardware, software maintenance, and services: When we sell software licenses, hardware, software maintenance and software services together, we account for the individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery. Revenue allocated to the services is recognized over time using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). Revenue for the software maintenance is recognized over time on a straight-line basis over the contract period. • Subscription-based software consisting of a software license and software maintenance: When subscription-based software is sold, the software license and software maintenance are generally considered distinct performance obligations. The transaction price is allocated to software license and the software maintenance based on relative SSP. We sell subscription-based software licenses for a fixed fee and/or a usage-based royalty fee, sometimes subject to a minimum guarantee. When the amount is in the form of a fixed fee, including the guaranteed minimum in usage-based royalty, revenue is allocated to the software license recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Any royalties not subject to the guaranteed minimum or earned in excess of the minimum amount are recognized as revenue when the subsequent usage occurs. Revenue allocated to the software maintenance is recognized on a straight-line basis over the contract period. Returns We do not offer rights of return for our products and services in the normal course of business. Customer Acceptance Our contracts with customers generally do not include customer acceptance clauses. Contract Balances When the timing of our delivery of goods or services is different from the timing of payments made by customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance). Customers that prepay are represented by the deferred revenue until the performance obligation is satisfied. Our contract assets consist of unbilled receivables. Our contract liabilities consisted of deferred (unearned) revenue, which is generally related to software maintenance contracts. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. The following table presents changes in our contract assets and liabilities during the years ended December 31, 2021 and 2020 (in thousands): Balance at Beginning of period Revenue Recognized In Advance of Billings Billings Balance at End of Period Year ended December 31, 2020 Contract Assets: Unbilled receivables $ 3,315 $ 1,508 $ (2,594 ) $ 2,229 Year ended December 31, 2021 Contract Assets: Unbilled receivables $ 2,229 $ 7,172 $ (6,314 ) $ 3,087 Balance at Beginning of period Billings Revenue Recognized Balance at End of Period Year ended December 31, 2020 Contract Liabilities: Deferred revenue $ 2,837 $ 6,619 $ (5,523 ) $ 3,933 Year ended December 31, 2021 Contract Liabilities: Deferred revenue $ 3,933 $ 6,486 $ (6,679 ) $ 3,740 Remaining Performance Obligations Remaining performance obligations represent the transaction price from contracts for which work has not been performed or goods and services have not been delivered. We expect to recognize revenue on approximately 67% of the remaining performance obligations over the next 12 months, with the remainder recognized thereafter. As of December 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations with a duration greater than one year, comprised of software maintenance contracts, was $2.6 million. Contract Costs We recognize an other asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain sales commissions meet the requirements to be capitalized, and we amortize these costs on a consistent basis with the pattern of transfer of the goods and services in the contract. Total capitalized costs to obtain a contract were immaterial during the periods presented and are included in other current and long-term assets on our consolidated balance sheets. We apply a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period is one year or less. These costs include sales commissions on software maintenance contracts with a contract period of one year or less as sales commissions paid on contract renewals are commensurate with those paid on the initial contract. Income Taxes – We compute deferred income taxes based on the differences between the financial statement and tax basis of assets and liabilities using enacted rates in effect in the years in which the differences are expected to reverse. We establish a valuation allowance to offset temporary deductible differences, net operating loss carryforwards and tax credits when it is more likely than not that the deferred tax assets will not be realized. We recognize the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position. Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact our tax provision in future periods. Interest and penalty charges, if any, related to unrecognized tax benefits would be classified as a provision for income tax in the consolidated statements of operations. Capitalization of Software Costs – We capitalize certain costs to develop software products to be sold, leased, or marketed to external users, after technological feasibility of the product has been established. No software costs were capitalized during the years ended December 31, 2021 and 2020, because such costs incurred subsequent to the establishment of technological feasibility, but prior to commercial availability, were immaterial. Software development costs also include costs to support our SaaS offerings. We capitalize development costs related to these software applications once the preliminary project stage is complete and it is probable that the projects will be completed. No software costs were capitalized during the years ended December 31, 2021 and 2020. Research and Development Costs – Costs incurred in the research and development of our products are expensed as incurred. Concentration of Credit Risk – At December 31, 2021 an |
Property and Equipment
Property and Equipment | 12 Months Ended |
Dec. 31, 2021 | |
Property Plant And Equipment [Abstract] | |
Property and Equipment | 3 PROPERTY AND EQUIPMENT Property and equipment consisted of the following at December 31 (in thousands): 2021 2020 Land $ 1,056 $ 1,056 Building and improvements 9,166 9,166 Computer and office equipment 1,310 1,283 Purchased software 155 154 Furniture and fixtures 778 778 Total 12,465 12,437 Less accumulated depreciation (9,249 ) (8,736 ) Property and equipment, net $ 3,216 $ 3,701 Depreciation expense was $0.5 |
Acquisitions
Acquisitions | 12 Months Ended |
Dec. 31, 2021 | |
Business Combinations [Abstract] | |
Acquisitions | 4. ACQUISTIONS In December 2021, we acquired 100% of the outstanding shares and acquired all of assets and liabilities of FortressID for a purchase price of $3.4 million, which consisted of $2.5 million of cash consideration and an earnout with a fair value of $0.9 million. The maximum earnout payment is $4.0 million and requires cash payments of up to $2.0 million for set revenue targets in 2022 and another $2.0 million for set revenue targets in 2023. The acquisition of FortressID, expands our offerings around identity proofing-enhancing its onboarding, verification and authentication offerings to directly address financial compliance requirements and enable organizations to mitigate risk and curtail increasing fraud. The acquisition was accounted for as a business combination, whereby all the assets acquired, and liabilities assumed were recognized at fair value on the acquisition date, with any excess of the consideration transferred over the fair value of the net assets acquired recognized as goodwill. Unaudited pro forma results of operations assuming the above acquisition had taken place at the beginning of each period are not provided because the historical operating results and pro forma results would not be materially different from reported results for the periods presented. The fair values recorded were based on a valuation performed by a third-party valuation specialist and the estimates and assumptions used in such valuation are subject to change, within the measurement period (up to one year from the acquisition date). The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands): Customer relationships $ 1,740 Developed technology 430 Trade name / trademarks 10 Goodwill 1,469 Gross assets acquired 3,649 Net working capital (11 ) Fair value of contingent consideration (919 ) Net assets acquired $ 2,719 After allocating the purchase price to the assets acquired and liabilities assumed based on their fair values at the date of acquisition, we recorded goodwill of approximately $1.5 million, which included $0.3 million related to the release of certain deferred tax assets. Goodwill largely consists of expected synergies to be realized from combining operations. The goodwill is deductible for income tax purposes. The fair values of intangible assets were based on valuations using the income approach. The fair value of intangible assets and their estimated useful live as of December 31, 2021 are as follows (dollars in thousands): Useful Life Gross Amount Accumulated Amortization Net Book Value Customer relationships 10 years $ 1,740 $ - $ 1,740 Developed technology 7 years 430 - 430 Trade name / trademarks 3 years 10 - 10 $ 2,180 $ - $ 2,180 In November 2020 The acquisition was accounted for as a business combination, whereby all the assets acquired, and liabilities assumed were recognized at fair value on the acquisition date, with any excess of the consideration transfer over the fair value of the net assets acquired recognized as goodwill. Unaudited pro forma results of operations assuming the above acquisition had taken place at the beginning of each period are not provided because the historical operating results and pro forma results would not be materially different from reported results for the periods presented. There were no measurement period adjustments recorded in the measurement period, which is now closed. The f air values recorded were based on a valuation performed by a third-party valuation specialist . The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands) : Net working capital, excluding deferred revenue $ 155 Customer relationships 940 Developed technology 280 Trade name / trademarks 20 Goodwill 1,651 Gross assets acquired 3,046 Deferred revenue (616 ) Net assets acquired $ 2,430 After allocating the purchase price to the assets acquired and liabilities assumed based on their fair values at the date of acquisition, we recorded goodwill of approximately $1.7 million. Goodwill largely consists of expected synergies to be realized from combining operations. The goodwill is deductible for income tax purposes. The fair values of intangible assets were based on valuations using the income approach. The fair value of intangible assets and their estimated useful live as of December 31, 2021are as follows (dollars in thousands): Useful Life Gross Amount Accumulated Amortization Net Book Value Customer relationships 8 years $ 940 $ 132 $ 808 Developed technology 5 years 280 63 217 Tradenames 7 years 20 3 17 $ 1,240 $ 198 $ 1,042 During the years ended December 31, 2021 and 2020 we recorded $176 thousand and $26 thousand of amortization expense on intangible assets, respectively. The Company expects to record amortization for the years ended December 31 as follows (in thousands): 2022 $ 415 2023 415 2024 415 2025 412 2026 412 Thereafter 1,153 $ 3,222 |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 5 . INCOME TAXES We recorded a benefit for income taxes of $0.3 million in the year ended December 31, 2021 related to a release of our valuation allowance as a result the deferred taxes recorded as part of the FortressID acquisition Year ended December 31, 2021 2020 Current: Federal $ - $ (1,397 ) State — (237 ) — (1,634 ) Deferred: Federal (147 ) — State (122 ) — (269 ) — Benefit from income taxes $ (269 ) $ (1,634 ) The 2021 difference between the effective tax rate and the U.S federal statutory rates was driven primarily due to the change in valuation allowance of our deferred tax assets. A reconciliation of the U.S. federal statutory rate to the effective tax rate is as follows: Year ended December 31, 2021 2020 Federal statutory rate 21 % 21 % State rate, net of federal benefit 6 6 Tax credits 2 3 Permanent adjustments — — Change in valuation allowance (24 ) (25 ) Expiration of statutes on uncertain tax positions — 2 Net operating loss carryback rate benefit under CARES Act — 11 Other (1 ) — Effective tax rate 4 % 18 % The 2020 difference between the effective tax rate and the U.S. feral statutory rates was driven primarily due to the change in valuation allowance of our deferred tax assets. This was partially offset by an income tax rate benefit related to a carryback of the 2020 net operating losses under the CARES Act. Deferred income taxes - We had deferred tax assets of $10.7 million and $8.7 million as of December 31, 2021 and 2020 respectively 2021 2020 Depreciation $ 367 $ 307 Stock-based compensation 405 121 Research and development credits 6,904 6,686 Net operating loss 3,380 1,352 Other 254 208 Total deferred tax assts 11,310 8,674 Valuation allowance (10,730 ) (8,674 ) Deferred tax liabilities Intangibles (580 ) — Total deferred tax liabilities (580 ) — Net deferred tax assets (liabilities) $ - $ - As of December 31, 2021, $6.9 million of our deferred tax assets relate to research credit carryforwards. We assessed the need for a valuation allowance on our deferred tax assets. We evaluated and considered all available evidence, both positive and negative, to determine whether, based on the weight of that evidence, a valuation allowance for deferred tax assets was needed. As part of this analysis, we gave more weight to recent, historical evidence than future projections as we consider the past more objective. As of December 31, 2021, we had a cumulative pretax loss over the most recent three-year period including a pretax loss of $6.1 million in 2021. We considered the cumulative loss for the year ended December 31, 2021 to be significant negative evidence in the overall analysis. Further, a significant portion of our deferred tax assets relates to federal and state research and development credits. These credits may only offset 75% of the tax liability after net operating loss carryforwards are utilized and thus, we have the risk that the credits could expire before utilization if sufficient taxable income in the carryforward periods doesn’t exist. As of December 31, 2021, we had a federal net operating loss carryforward of $7.3 million, which may be available to offset future income tax liabilities and can be carried forward indefinitely. As of December 31, 2021, we had State NOL carryforwards of $16.7 million, respectively, which expire at various dates though 2041. We evaluated the positive and negative evidence bearing upon the realizability of our deferred tax assets, which are composed principally of net operating loss carryforwards and research and development credits. Under the applicable accounting standards, we considered our history of losses and concluded that is more likely that we will not recognize the benefits of feral and state deferred tax assets. Therefore, we have recorded a full valuation allowance of $10.7 million and $8.7 million at December 31, 2021 and 2020, respectively. During the year ended December 31, 2021, we increased the valuation allowance by $2.0 million from the prior year end. We will continue to monitor the evidence and the realizability of our deferred tax assets in future periods. Should evidence regarding the realizability of our deferred tax assets change at a future point in time, we will adjust the valuation allowance as required. Under Internal Revenue Code Section 382, if a corporation undergoes an “ownership change,” the corporation’s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income may be limited. In connection with our acquisition of FortressID during 2021, the historical NOL carryforwards of $3.5 million from FortressID are likely limited under Section 382 due to a change in ownership triggered by the acquisition, however, we do not expect the limitation to result in any of the NOL carryforwards to expire unused. We have not completed a study at the Aware, Inc. level to assess whether an “ownership change” has occurred or whether there have been multiple ownership changes since we became a “loss corporation” as defined in Section 382. Future changes in our stock ownership, which may be outside of our control, may trigger an “ownership change.” In addition, future equity offerings or acquisitions that have equity as a component of the purchase price could result in an “ownership change.” If an “ownership change” has occurred or does occur in the future, utilization of the NOL carryforwards or other tax attributes may be limited, which could potentially result in increased future tax liability to us. Uncertain tax benefits - A roll forward of the uncertain tax position that was primarily related to our research and development tax credits is as follows (in thousands): Uncertain tax positions at December 31, 2019 $ 1,008 Increase due to positions taken in prior periods (206 ) Uncertain tax positions at December 31, 2020 802 Decrease due to positions taken in prior periods — Uncertain tax positions at December 31, 2021 $ 802 Uncertain tax positions of $0.8 million will impact our tax rate if realized. Tax examinations – We file tax returns as prescribed by the tax laws of the jurisdictions in which we operate. In the normal course of business, we are subject to examination by federal and state jurisdictions, where applicable. The earliest tax years that remain subject to examination by jurisdiction is 2018 for both federal and Massachusetts. However, to the extent the Company utilizes net operating losses or credits from years prior to 2018, the statute remains open to the extent of the net operating losses or other credits are utilized. |
Equity and Stock Compensation P
Equity and Stock Compensation Plans | 12 Months Ended |
Dec. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Equity and Stock Compensation Plans | 6 . EQUITY AND STOCK COMPENSATION PLANS Stock Option Plan – We have one active fixed stock option plan which is our 2001 Nonqualified Stock Plan (“2001 Plan”). We are authorized to grant nonqualified stock options, stock appreciation rights and stock awards to our employees and directors for up to 8,000,000 shares of common stock under this plan. As of December 31, 2021, there were 889,262 shares available for grant under the 2001 Plan. Options are granted at exercise prices as determined by the Board of Directors and have a term of up to a maximum The following table presents stock-based compensation expenses included in our consolidated statements of operations (in thousands): Years ended December 31, 2021 2020 Cost of services $ 23 $ 17 Research and development 261 188 Selling and marketing 250 168 General and administrative 1,033 465 Stock-based compensation expense $ 1,567 $ 838 Stock-based compensation expense in the preceding table includes expenses associated with grants of: i) stock options, ii) unrestricted shares of our common stock; and iii) performance share awards. The methods used to determine stock-based compensation expense for each type of equity grant are described in the following paragraphs. Stock Option Grants. For the years ended December 31, 2021 and 2020, we granted stock options for 2,875,000 and 50,000 shares of our common stock, respectively. We estimate the fair value of those stock options using the Black-Scholes valuation model. The Black-Scholes valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. We do not estimate our forfeiture rates as the actual forfeiture rate is known at the end of each reporting period due to the timing of our stock option vesting. We believe that the valuation technique and the approach utilized to develop the underlying assumptions are appropriate in calculating the fair values of stock options granted in the year s ended December 31, 20 2 1 and 2020 . Estimates of fair value are not intended to predict actual future events or the value ultimately realized by persons who receive equity awards. Specific assumptions used to determine the fair value of options granted during the years ended December 31, 2021 and 2020, using the Black-Scholes valuation model were as follows: Years ended December 31, 2021 2020 Expected term (1) 6.26 years 6.14 years Expected volatility factor (2) 39 % 37 % Risk-free interest rate (3) 0.6 % 0.6 % Expected annual dividend yield n/a n/a (1) The expected term for each grant was determined based on the simplified method. (2) The expected volatility for each grant is estimated based on an average of historical volatility over the expected term of the stock options. (3) The risk-free interest rate for each grant is based on the U.S. Treasury yield curve in effect at the time of grant for a period equal to the expected term of the stock option. Unrestricted Stock Grants . Our 2001 Plan permits us to grant shares of unrestricted stock to our directors, officers, and employees. Stock-based compensation expense for stock grants is determined based on the fair market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant date. We granted 56,553, and 256,250 shares of unrestricted stock during the years ended December 31, 2021, and 2020, respectively. In 2021, we granted 56,553 shares of unrestricted stock to directors. The shares were issued in two equal installments shortly after June 30, 2021 and December 31, 2021. We expensed $0.3 million of stock-based compensation expense related to these grants in the year ended December 31, 2021. There was no unamortized stock-based compensation charge associated with these stock grants as of December 31, 2021. In 2020, we granted 256,250 shares of unrestricted stock to directors, officers, and employees. In March and May 2020, we granted 243,000 shares of unrestricted stock to directors, officers, and employees. The shares were issued in two equal installments shortly after June 30, 2020 and December 31, 2020. In October and November, we granted 13,250 shares of unrestricted stock to employees. The shares were issued shortly after December 31, 2020. We expensed $0.7 million of stock-based compensation expense related to these grants in the year ended December 31, 2020. There was no unamortized stock-based compensation charge associated with these stock grants as of December 31, 2020. We also, granted 120,000 shares in September and October 2019 to be issued in four equal installments shortly after the anniversaries of their grant dates in September and October of 2020, 2021, 2022, and 2023, provided the grantee is serving as a director, officer, or employee on those dates. The total stock-based compensation expense related to the 120,000 shares granted in 2019 was $0.4 million, of which $23,000 was charged to expense in 2019, and $84,000 was charged to expense in the each 2020 and 2021. We anticipate the remaining $145,000 will be charged to expense ratably through 2023. 2021 2020 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Outstanding at beginning of year 425,000 $ 6.00 435,000 $ 6.00 Granted 2,875,000 $ 4.73 50,000 $ 6.00 Exercised — — — — Forfeited or cancelled 60,000 $ 4.73 60,000 $ 6.00 Outstanding at end of year 3,240,000 $ 4.97 425,000 $ 6.00 Exercisable at year end 218,748 $ 6.00 112,496 $ 6.00 Total options outstanding at December 31, 2021 were 3,240,000. 218,748 of those options were vested and had a weighted average exercise price of $6.00. Options to purchase up to 2,875,000 and 50,000 shares of our common stock were granted in the years ended December 31, 2021 and 2020 respectively. At December 31, 2021, the weighted average remaining contractual term for total options outstanding and total options exercisable was approximately 9.00 and 7.92 years, respectively. At December 31, 2021, the aggregate intrinsic value of options outstanding and options exercisable was zero. The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The following table summarizes the stock options outstanding at December 31, 2021: Options Outstanding Options Exercisable Exercise Price Range Number Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Number Weighted Average Exercise Price $4 to $5 2,921,250 $ 4.72 9.11 54,687 $ 4.50 $5 to $6 106,250 $ 5.50 7.83 54,687 $ 5.50 $6 to $7 106,250 $ 6.50 7.83 54,687 $ 6.50 $7 to $8 106,250 $ 7.50 7.83 54,687 $ 7.50 3,240,000 $ 4.97 9.00 218,748 $ 6.00 At December 31, 2021, unrecognized compensation expense related to non-vested stock options was approximately $4.2 million, which is expected to be recognized over a weighted average period of 3.0 years. We issue common stock from previously authorized but unissued shares to satisfy option exercises and purchases under our Employee Stock Purchase Plan. Employee Stock Purchase Plan – In May 2021, we adopted the 2021 Employee Stock Purchase Plan (“2021 ESPP Plan”) under which eligible employees could purchase common stock at a price equal to 85% of the lower of the fair market value of the common stock at the beginning or end of each six-month S tock-based compensation expense related to our 2021 ESPP Plan for the year ended December 31, 2021 was $0.1 million. Participation in the 2021 ESPP Plan is limited to $25,000 worth of stock for each calendar year and may be terminated at any time by the employee and automatically ends on termination of employment. A total of 1,000,000 shares of common stock have been reserved for issuance. As of December 31, 2021, there were 945,501 shares available for future issuance under the 2021 ESPP Plan. We issued 54,499 and 6,972 under the 2021 ESPP Plan and 1996 ESPP Plan, respectively, during the year ended December 31, 2021. We issued 15,388 common shares under the 1996 ESPP Plan during the year ended December 31, 2020. Share Purchases - On April 30, 2020, our Board of Directors approved a program authorizing to purchase up to $10 million of our common stock, of which $1.0 million had been utilized as of December 31, 2021. We did not purchase any shares in the year ended December 31, 2021. During the year ended December 31, 2020, we repurchased 298,214 shares of our common stock. The shares were purchased from time to time in the open market at management’s discretion, depending upon market conditions and other factors. The authorization to repurchase Company stock expired on December 31, 2021. Repurchases where made under the program using our own cash resources and will been accordance with Rule 10b-18 under the Securities Exchange Act of 1934 and other applicable laws, rules and regulations. The program did not obligate us to acquire any particular amount of common stock and the program may be modified or suspended at any time at our Board of Directors discretion. Dividends – We did not pay dividends in the years ended December 31, 2021 and 2020. |
Commitments and Contingent Liab
Commitments and Contingent Liabilities | 12 Months Ended |
Dec. 31, 2021 | |
Commitments And Contingencies Disclosure [Abstract] | |
Commitments and Contingent Liabilities | 7 . COMMITMENTS AND CONTINGENT LIABILITIES Lease Commitments – We own our principal office and research facility in Bedford, Massachusetts, which we have occupied since November 1997. We have no real estate lease commitments and no equipment lease commitments. Litigation - There are no material pending legal proceedings to which we are a party or to which any of our properties are subject which, either individually or in the aggregate, are expected to have a material adverse effect on our business, financial position or results of operations. Guarantees and Indemnification Obligations – We enter into agreements in the ordinary course of business that require us: i) to perform under the terms of the contracts, ii) to protect the confidentiality of our customers’ intellectual property, and iii) to indemnify customers, including indemnification against third party claims alleging infringement of intellectual property rights. We also have agreements with each of our directors and executive officers to indemnify such directors or executive officers, to the extent legally permissible, against all liabilities reasonably incurred in connection with any action in which such individual may be involved by reason of such individual being or having been a director or officer of the Company. Given the nature of the above obligations and agreements, we are unable to make a reasonable estimate of the maximum potential amount that we could be required to pay. Historically, we have not made any significant payments on the above guarantees and indemnifications and no amount has been accrued in the accompanying consolidated financial statements with respect to these guarantees and indemnifications. |
Employee Benefit Plan
Employee Benefit Plan | 12 Months Ended |
Dec. 31, 2021 | |
Compensation And Retirement Disclosure [Abstract] | |
Employee Benefit Plan | 8 . EMPLOYEE BENEFIT PLAN In 1994, we established a qualified 401(k) Retirement Plan (the “Plan”) under which employees are allowed to contribute certain percentages of their pay, up to the maximum allowed under Section 401(k) of the Internal Revenue Code. Our contributions to the Plan are at the discretion of the Board of Directors. Our contributions were approximately $0.4 and $0.3 million in 2021 and 2020, respectively. |
Net Loss Per Share
Net Loss Per Share | 12 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Net Loss Per Share | 9 . NET LOSS PER SHARE The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive (in thousands): Year ended December 31, 2021 2020 Stock options 2,823 433 Net loss per share is calculated as follows (in thousands, except per share data): Year ended December 31, 2021 2020 Net loss (5,824 ) (7,614 ) Shares outstanding: Weighted-average common shares outstanding 21,525 21,473 Additional dilutive common stock equivalents — — Diluted shares outstanding 21,525 21,473 Net loss per share – basic $ (0.27 ) $ (0.35 ) Net loss per share - diluted $ (0.27 ) $ (0.35 ) |
Potential Sale of Building
Potential Sale of Building | 12 Months Ended |
Dec. 31, 2021 | |
Potential Sale Of Building [Abstract] | |
Potential Sale of Building | 10. POTENTIAL SALE OF BUILDING On April 26, 2021 (the “Contract Date”), we entered into an Agreement of Purchase and Sale (the “Purchase and Sale Agreement”) with FDS Bedford, LLC or its designee (the “Purchaser”). The Purchase and Sale Agreement provided that we are obligated to sell the property at 40 Middlesex Turnpike, Bedford, Massachusetts (the “Property”) to the Purchaser for $8,875,000 (the “Transaction”), subject to the satisfaction or waiver on or before the closing of the conditions set forth in the Purchase and Sale Agreement. The Purchaser is under no obligation to complete the Transaction. The Purchaser deposited $125,000 with a title company following the Contract Date which is non-refundable. The deposit will be credited against the $8,875,000 purchase price at the closing. We anticipate the sale of the building, if it occurs, to be in the second or third quarter of 2022. We currently occupy the Property. We are entitled to continue to occupy the Property for a period of approximately six months following the Closing at no cost to us. We are obligated to maintain the Property we occupy in first class condition and repair during this period. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | 11. SUBSEQUENT EVENTS Lease agreement - On March 1, 2022, we entered into a lease agreement with 76/80 Burlington Group LLC (the “Lease”). Pursuant to the Lease, we leased approximately 20,730 rentable square feet at 76 Blanchard Road in Burlington, Massachusetts (the “Premise”) for a term of ten years and six months, which includes a one-time termination right after seven years and six months. We intend to use as our principal executive offices. The term of the Lease commences on the date that the landlord notifies us that the planned construction on the Premise is substantially complete. The Lease provides for an aggregate of $8.2 million of rent due over the Lease term and also provides a renewal option for up to two additional terms of five years each. Subscription agreement - On March 11, 2022, concurrent with our entry into a mutual reseller arrangement with MIRACL Technologies Limited (“MIRACL”), we entered into a subscription agreement with Omlis Limited, a limited company incorporated and registered in England and Wales and the parent of MIRACL (“Omlis”). We purchased $2.5 million of Omlis’ Convertible Note (“Note”) that accrues at 5% annually with a maturity date of March 11, 2026. Prior to maturity, we have the right to convert into a future financing at a 20% discount from the price per share paid by the investors. If the Note remains outstanding on the maturity date, the Note shall, at the option of the holders of a majority of the outstanding Note, (i) be converted into the most senior shares in Omlis, (ii) be redeemed by payment in cash of the Note and all accrued but unpaid interest or (iii) remain outstanding. In connection with the sale of the Note, Omlis granted us a right of first refusal for 18 months with respect to any proposed sale by Omlis of equity securities constituting 20% or more of the outstanding voting power of Omlis or all or substantially all of the assets of Omlis or any of its material subsidiaries. Also, in connection with the sale of the Note, Omlis issued us a warrant that expires on September 11, 2023 which allows us to purchase up to 8% of the total equity shares in Omlis at a price per share of $33.91. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation - The consolidated financial statements include the accounts of Aware, Inc. and its subsidiaries (“the Company”). All significant intercompany transactions have been eliminated. |
Use of Estimates | Use of Estimates – The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. The most significant estimates included in the financial statements pertain to revenue recognition, reserves for doubtful accounts, valuation of acquired assets and assumed liabilities in business combinations, earn-out liability, goodwill and long-lived asset impairment and valuation allowance for deferred income tax assets. Actual results could differ from those estimates. |
Fair Value Measurements | Fair Value Measurements - The Financial Accounting Standards Board (“FASB”) Codification defines fair value and establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to the unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). The three levels of the fair value hierarchy under the FASB Codification are: i) Level 1 – valuations that are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date; ii) Level 2 – valuations that are based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly; and iii) Level 3 – valuations that require inputs that are both significant to the fair value measurement and unobservable. Cash and cash equivalents, which primarily include money market mutual funds, were $30.0 million and $38.6 million at December 31, 2021 and 2020, respectively. We classified our cash equivalents of $29.0 million and $37.9 million as of December 31, 2021 and 2020, respectively, within Level 1 of the fair value hierarchy because they are valued using quoted market prices. Our cash equivalents are measured at fair value on a recurring basis and their carrying values approximate their respective fair values. As of December 31, 2021, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2021 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Assets: Money market funds (included in cash and cash equivalents) $ 28,952 $ - $ - Total assets $ 28,952 $ - $ - Liabilities: Contingent acquisition payment $ - $ - $ 919 Total liabilities $ - $ - $ 919 The fair value of our contingent acquisition payment was determined using a Monte Carlo simulation and there was no change in fair value from the initial recording date (acquisition date) to December 31, 2021 due to the proximity of the acquisition to year-end. As of December 31, 2020, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 37,948 $ - $ - Total $ 37,948 $ - $ - |
Cash and Cash Equivalents | Cash and Cash Equivalents – Cash and cash equivalents, which consist primarily of money market funds and demand deposits, are stated at fair value. All highly liquid investments purchased with an original maturity of three months or less are considered cash equivalents. Our cash balances exceed the Federal Deposit Insurance Corporation limits. The Company does not believe it is exposed to significant credit risk related to cash and cash equivalents. |
Allowance for Doubtful Accounts | Allowance for Doubtful Accounts – Accounts are charged to the allowance for doubtful accounts as they are deemed uncollectible based on a periodic review of the accounts. For the years ended December 31, 2021 and 2020, changes to and ending balances of the allowance for doubtful accounts were as follows (in thousands): Years ended December 31, 2021 2020 Allowance for doubtful accounts balance - beginning of year $ 138 $ 20 Additions to the allowance for doubtful accounts - 118 Deductions against the allowance for doubtful accounts (64 ) - Allowance for doubtful accounts balance - end of year $ 74 $ 138 |
Property and Equipment | Property and Equipment – Property and equipment is stated at cost. Depreciation and amortization of property and equipment is provided using the straight-line method over the estimated useful lives of the assets. Upon retirement or sale, the costs of the assets disposed of and the related accumulated depreciation are removed from the accounts and any resulting gain or loss on disposal is included in the determination of income or loss. Expenditures for repairs and maintenance are charged to expense as incurred. The estimated useful lives of assets are: Building 30 years Building improvements 5 to 20 years Furniture and fixtures 5 years Computer and office equipment 3 years Purchased software 3 years |
Goodwill | Goodwill – We record goodwill when consideration paid in a business acquisition exceeds the value of the net assets acquired. Our estimates of fair value are based upon assumptions believed to be reasonable at the time, but such estimates are inherently uncertain and unpredictable. Assumptions may be incomplete or inaccurate and unanticipated events or circumstances may occur, which may affect the accuracy of validity of such assumptions, estimates or actual results. Goodwill is not amortized but rather is tested for impairment annually in the fourth quarter or more frequently, if facts and circumstances warrant a review. Circumstances that could trigger an impairment test include, but are not limited to, a significant adverse change in the business climate or legal factors, an adverse action or assessment by a regulator, or unanticipated competition. We have determined that there is a single reporting unit for the purpose of conducting the goodwill impairment assessment. In accordance with ASC Topic 350, Intangibles—Goodwill and Other, we first assess qualitative factors to determine whether it is necessary to perform the quantitative goodwill impairment test. If after assessing the totality of events or circumstances, we determine that it is more likely than not (i.e., greater than 50% likelihood) that the fair value of the reporting unit is less than its carrying amount, then the quantitative test is required. The quantitative goodwill impairment test requires us to estimate and compare the fair value of the reporting unit, determined using an income approach and a market approach, with its carrying value. If the fair value of the reporting unit exceeds the carrying value of the net assets, goodwill is not impaired. If the fair value of the reporting unit is less than the carrying value, the difference is recorded as an impairment loss up to the amount of goodwill. Application of the goodwill impairment test requires judgments, including identification of the reporting units, assigning goodwill to reporting units, a qualitative assessment to determine whether there are any impairment indicators, and determining the fair value of each reporting unit which often involves the use of significant estimates and assumptions, including assumptions with respect to future cash inflows and outflows, discount rates, asset lives and market multiples, among other items. There is no assurance that the actual future earnings or cash flows of the reporting unit will not decline significantly from the projections used in the impairment analysis. Goodwill impairment charges may be recognized in future periods to the extent changes in factors or circumstances occur, including deterioration in the macroeconomic environment and industry, deterioration in the Company’s performance or its future projections, or changes in plans for its reporting unit. The changes in goodwill for the years ended December 31, 2021 and 2020 were as follows (in thousands): As of December 31, 2021 and 2020, we had $3.1 and $1.7 million of goodwill, respectively. Changes in the valuation of goodwill could materially impact our operating results and financial position. We performed a quantitative analysis during the year ended December 31, 2021 and determined there was no impairment loss and to date, there have been no impairments of goodwill. |
Valuation of Long-Lived Assets | Valuation of Long-Lived Assets – We review long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate. Each impairment test is based on a comparison of the undiscounted cash flows estimated to be generated by those assets over their estimated economic life to the related carrying value of those assets to determine if the assets are impaired. If an impairment is indicated, the asset is written down to its estimated fair value. The cash flow estimates used to identify the potential impairment reflect our best estimates using appropriate assumptions and projections at that time. In evaluating potential impairment of these assets, we specifically consider whether any indicators of impairment are present, including, but not limited to: • whether there has been a significant adverse change in the business climate that affects the value of an asset: • whether there has been a significant change in the extent or way an asset is used; and • whether there is an expectation that the asset will be sold or disposed of before the end of its originally estimated useful life. We did not identify any events or changes in business circumstances that the carrying amount of the assets may not be fully recoverable or that the useful lives of these assets are no longer appropriate during the years ended December 31, 2021 and 2020. |
Revenue Recognition | Revenue recognition . The core principle of Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”) is that we should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which we expect to be entitled in exchange for those goods or services. To achieve that core principle, we apply the following five step model: 1) Identify the contract with the customer A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the related payment terms, (ii) the contract has commercial substance, and (iii) we determine that collection of substantially all consideration for goods and services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. We apply judgment in determining the customer’s intent and ability to pay, which is based on a variety of factors including the customer’s historical payment experience, or in the case of a new customer, published credit and financial information pertaining to the customer. We evaluate contract modifications for the impact on revenue recognition if they have been approved by both parties such that the enforceable rights and obligations under the contract have changed. Contract modifications are either accounted for using a cumulative effect adjustment or prospectively over the remaining term of the arrangement. The determination of which method is more appropriate depends on the nature of the modification, which we evaluate on a case-by-case basis. We combine two or more contracts entered into at or near the same time with the same customer and account for them as a single contract if (i) the contracts are negotiated as a package with a common commercial objective, (ii) the amount of consideration to be paid in one contract depends on the price or performance of the other contract, or (iii) some or all of the goods or services in one contract would be combined with some or all of the goods and services in the other contract into a single performance obligation. If two or more contracts are combined, the consideration to be paid is aggregated and allocated to the individual performance obligations without regard to the consideration specified in the individual contracts. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the goods and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the good or service either on its own or together with other available resources, and are distinct in the context of the contract, whereby the transfer of the good or service is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised goods and services, we apply judgment to determine whether promised goods and services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised goods and services are accounted for as a combined performance obligation. To identify performance obligations, we consider all of the goods or services promised in a contract regardless of whether they are explicitly stated or are implied by customary business practices. 3) Determine the transaction price The transaction price is determined based on the consideration we expect to be entitled in exchange for transferring promised goods and services to the customer. Determining the transaction price requires significant judgment. To the extent the transaction price includes variable consideration, we estimate the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur. Any estimates, including the effect of the constraint on variable consideration, are evaluated at each reporting period. Some of our arrangements include usage-based royalties where a software license is the predominant item that the royalty relates to. In these arrangements, revenue from the usage-based royalty is recognized when the subsequent usage occurs. The amount of consideration is not adjusted for a significant financing component if the time between payment and the transfer of the related good or service is expected to be one year or less under the practical expedient in ASC 606-10-32-18. Our revenue arrangements are typically accounted for under such expedient, as payment is typically due within 30 to 60 days. As of December 31, 2021 and 2020, none of our contracts contained a significant financing component. Our arrangements can include variable fees, such as the option to purchase additional usage of a previously delivered software license. The Company may also provide pricing concessions to clients, a business practice that also gives rise to variable fees in contracts. The Company also reviews contractual termination provisions in determining contractual term and total transaction price. For variable fees arising from the client’s purchase of additional usage of a previously delivered software license, we apply the sales and usage-based royalties guidance related to a license of intellectual property and recognizes the revenue in the period the underlying sale or usage occurs. We include variable fees in the determination of total transaction price if it is not probable that a future significant reversal of revenue will occur. We use the expected value or most likely value amount, whichever is more appropriate for specific circumstances, to estimate variable consideration, and the estimates are based on the level of historical price concessions offered to clients. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price (“SSP”) basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation. The consideration to be received is allocated among the separate performance obligations based on relative SSPs. The SSP is the price at which we would sell a promised good or service separately to a customer. The best estimate of SSP is the observable price of a good or service when we sell that good or service separately. A contractually stated price or a list price for a good or service may be the SSP of that good or service. We use a range of amounts to estimate SSP when we sell each of the goods and services separately and need to determine whether there is a discount that needs to be allocated based on the relative SSP of the various goods and services. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, we typically determine the SSP using an adjusted market assessment approach using information that may include market conditions and other observable inputs. We typically have more than one SSP for individual goods and services due to the stratification of those goods and services by customers and circumstances. In these instances, we may use information such as the nature of the customer and distribution channel in determining the SSP. 5) Recognize revenue when or as we satisfy a performance obligation We satisfy performance obligations either over time or at a point in time. Revenue is recognized over time if 1) the customer simultaneously receives and consumes the benefits provided by our performance, 2) our performance creates or enhances an asset that the customer controls as the asset is created or enhanced, or 3) our performance does not create an asset with an alternative use to us and we have an enforceable right to payment for performance completed to date. If we do not satisfy a performance obligation over time, the related performance obligation is satisfied at a point in time by transferring the control of a promised good or service to a customer. We categorize revenue as software licenses, software maintenance, or services and other. Specific revenue recognition policies apply to each category of revenue. Software licenses Software licenses consist of revenue from the sale of software licenses for biometrics and imaging applications. Our software licenses are functional intellectual property and typically provide customers with the right to use our software on a term or perpetual basis as it exists when made available to the customer. We recognize revenue from perpetual software licenses at a point in time upon delivery, provided all other revenue recognition criteria are met. We also offer certain products pursuant to a subscription-based software model which includes a term software license to use the software for a fixed term. We recognize revenue for fixed fees associated with subscription-based software licenses at a point in time upon delivery, provided all other revenue recognition criteria are met. Fees subject to the usage-based royalty exception are recognized when the subsequent usage occurs. Also, with our acquisition of FortressID and adaption of our current products to be delivered in a hosted environment with AwareID, we expect to recognize revenue from our SaaS offerings in future periods. SaaS offerings are recognized ratably over the subscription period. For the year ended December 31, 2021 we did not generate revenue from SaaS contracts. Software maintenance Software maintenance consists of revenue from the sale of software maintenance contracts for biometrics and imaging software. Software maintenance contracts entitle customers to receive software support and software updates, if and when they become available, during the term of the maintenance contract. Software support and software updates are considered distinct services. However, these distinct services are considered a single performance obligation consisting of a series of distinct services that are substantially the same and have the same pattern of transfer to the customer. We recognize software maintenance revenue over time on a straight-line basis over the contract period. Services Service revenue consists of fees from biometrics customers for software engineering services. We recognize services revenue over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted), provided all other revenue recognition criteria are met. The use of the over-time revenue recognition method requires judgment in developing budgeted labor hours. Changes in budgeted hours may occur and the resulting impact on revenue recognition is accounted for in the period of the change in estimate. Arrangements with multiple performance obligations In addition to selling software licenses, software maintenance and software services on a standalone basis, a significant portion of our contracts include multiple performance obligations. The various combinations of multiple performance obligations and our revenue recognition for each are described as follows: • Perpetual software licenses and software maintenance: When software licenses and software maintenance contracts are sold together, the software licenses and software maintenance are generally considered distinct performance obligations. The transaction price is allocated to the software licenses and the software maintenance based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Revenue allocated to the software maintenance is recognized over time on a straight-line basis over the contract period. • Perpetual software licenses and services: When software licenses and significant customization engineering services are sold together, they are accounted for as a combined performance obligation, as the software licenses are generally highly dependent on, and interrelated with, the associated services and therefore are not distinct performance obligations. Revenue for the combined performance obligation is recognized over time as the services are delivered using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). When software licenses and standard implementation or consulting-type services are sold together, they are generally considered distinct performance obligations, as the software licenses are not dependent on or interrelated with the associated services. The transaction price in these arrangements is allocated to the software licenses and services based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Revenue allocated to the services is recognized over time using an input method. In arrangements with both software licenses and services, the software license portion of the arrangement is classified as software license revenue and the services portion is classified as services revenue in our consolidated statements of operations. • Perpetual software licenses, software maintenance and services: When we sell software licenses, software maintenance and software services together, we account for the individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery. Revenue allocated to the services is recognized over time using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). Revenue for the software maintenance is recognized over time on a straight-line basis over the contract period. However, if the software services are significant customization engineering services, they are accounted for with the software licenses as a combined performance obligation, as stated above. Revenue for the combined performance obligation is recognized over time using an input method. • Perpetual software licenses, hardware, software maintenance, and services: When we sell software licenses, hardware, software maintenance and software services together, we account for the individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations based on relative SSP. Revenue allocated to the software licenses is recognized at a point in time upon delivery. Revenue allocated to the services is recognized over time using an input method (i.e., labor hours incurred as a percentage of total labor hours budgeted). Revenue for the software maintenance is recognized over time on a straight-line basis over the contract period. • Subscription-based software consisting of a software license and software maintenance: When subscription-based software is sold, the software license and software maintenance are generally considered distinct performance obligations. The transaction price is allocated to software license and the software maintenance based on relative SSP. We sell subscription-based software licenses for a fixed fee and/or a usage-based royalty fee, sometimes subject to a minimum guarantee. When the amount is in the form of a fixed fee, including the guaranteed minimum in usage-based royalty, revenue is allocated to the software license recognized at a point in time upon delivery, provided all other revenue recognition criteria are met. Any royalties not subject to the guaranteed minimum or earned in excess of the minimum amount are recognized as revenue when the subsequent usage occurs. Revenue allocated to the software maintenance is recognized on a straight-line basis over the contract period. Returns We do not offer rights of return for our products and services in the normal course of business. Customer Acceptance Our contracts with customers generally do not include customer acceptance clauses. Contract Balances When the timing of our delivery of goods or services is different from the timing of payments made by customers, we recognize either a contract asset (performance precedes contractual due date) or a contract liability (customer payment precedes performance). Customers that prepay are represented by the deferred revenue until the performance obligation is satisfied. Our contract assets consist of unbilled receivables. Our contract liabilities consisted of deferred (unearned) revenue, which is generally related to software maintenance contracts. We classify deferred revenue as current or noncurrent based on the timing of when we expect to recognize revenue. The following table presents changes in our contract assets and liabilities during the years ended December 31, 2021 and 2020 (in thousands): Balance at Beginning of period Revenue Recognized In Advance of Billings Billings Balance at End of Period Year ended December 31, 2020 Contract Assets: Unbilled receivables $ 3,315 $ 1,508 $ (2,594 ) $ 2,229 Year ended December 31, 2021 Contract Assets: Unbilled receivables $ 2,229 $ 7,172 $ (6,314 ) $ 3,087 Balance at Beginning of period Billings Revenue Recognized Balance at End of Period Year ended December 31, 2020 Contract Liabilities: Deferred revenue $ 2,837 $ 6,619 $ (5,523 ) $ 3,933 Year ended December 31, 2021 Contract Liabilities: Deferred revenue $ 3,933 $ 6,486 $ (6,679 ) $ 3,740 Remaining Performance Obligations Remaining performance obligations represent the transaction price from contracts for which work has not been performed or goods and services have not been delivered. We expect to recognize revenue on approximately 67% of the remaining performance obligations over the next 12 months, with the remainder recognized thereafter. As of December 31, 2021, the aggregate amount of the transaction price allocated to remaining performance obligations with a duration greater than one year, comprised of software maintenance contracts, was $2.6 million. Contract Costs We recognize an other asset for the incremental costs of obtaining a contract with a customer if we expect the benefit of those costs to be longer than one year. We have determined that certain sales commissions meet the requirements to be capitalized, and we amortize these costs on a consistent basis with the pattern of transfer of the goods and services in the contract. Total capitalized costs to obtain a contract were immaterial during the periods presented and are included in other current and long-term assets on our consolidated balance sheets. We apply a practical expedient to expense costs as incurred for costs to obtain a contract when the amortization period is one year or less. These costs include sales commissions on software maintenance contracts with a contract period of one year or less as sales commissions paid on contract renewals are commensurate with those paid on the initial contract. |
Income Taxes | Income Taxes – We compute deferred income taxes based on the differences between the financial statement and tax basis of assets and liabilities using enacted rates in effect in the years in which the differences are expected to reverse. We establish a valuation allowance to offset temporary deductible differences, net operating loss carryforwards and tax credits when it is more likely than not that the deferred tax assets will not be realized. We recognize the tax benefit from an uncertain tax position only if it is more-likely-than-not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the tax position. The evaluation of an uncertain tax position is based on factors that include, but are not limited to, changes in the tax law, the measurement of tax positions taken or expected to be taken in tax returns, the effective settlement of matters subject to audit, and changes in facts or circumstances related to a tax position. Any changes to these estimates, based on the actual results obtained and/or a change in assumptions, could impact our tax provision in future periods. Interest and penalty charges, if any, related to unrecognized tax benefits would be classified as a provision for income tax in the consolidated statements of operations. |
Capitalization of Software Costs | Capitalization of Software Costs – We capitalize certain costs to develop software products to be sold, leased, or marketed to external users, after technological feasibility of the product has been established. No software costs were capitalized during the years ended December 31, 2021 and 2020, because such costs incurred subsequent to the establishment of technological feasibility, but prior to commercial availability, were immaterial. Software development costs also include costs to support our SaaS offerings. We capitalize development costs related to these software applications once the preliminary project stage is complete and it is probable that the projects will be completed. No software costs were capitalized during the years ended December 31, 2021 and 2020. |
Research and Development Costs | Research and Development Costs – Costs incurred in the research and development of our products are expensed as incurred. |
Concentration of Credit Risk | Concentration of Credit Risk – At December 31, 2021 and 2020, we had cash and cash equivalents, in excess of federally insured deposit limits of approximately $29.7 million and $38.3 million, respectively. Concentration of credit risk with respect to net accounts receivable and unbilled receivables consisted of amounts owed by the following customers that comprised more than 10% of net accounts receivable and unbilled receivables at December 31: 2021 2020 Customer A 27 % 39 % Customer B - 13 % We had no customer in 2021 or 2020 that provided 10% or more of revenue. |
Stock-based Compensation | Stock-Based Compensation – We grant stock and stock options to our employees and directors. We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize stock-based compensation expense on a straight-line basis over the requisite service period of the award. For stock awards, we determine the fair value of the award by using the fair market value of our stock on the date of grant; provided the number of shares in the grant is fixed on the grant date. For stock options, we use the Black-Scholes option valuation model to estimate the fair value of the award. This valuation model takes into account the exercise price of the award, as well as a variety of significant assumptions. The assumptions used to estimate the fair value of stock options include the expected term, the expected volatility of our stock over the expected term, the risk-free interest rate over the expected term, and our expected annual dividend yield. |
Computation of Earnings per Share | Computation of Earnings per Share – Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding plus additional common shares that would have been outstanding if dilutive potential common shares had been issued. For the purposes of this calculation, stock options are considered common stock equivalents in periods in which they have a dilutive effect. Stock options that are antidilutive are excluded from the calculation. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments – The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value because of their short-term nature. |
Segments | Segments – We organize ourselves into a single segment reporting to the chief operating decision maker, who we have designated as our Chief Executive Officer. We conduct our operations in the United States and sell our products and services to domestic and international customers. Revenues were generated from the following geographic regions (in thousands): Year ended December 31, 2021 2020 United States $ 9,624 $ 6,724 Brazil 1,938 975 United Kingdom 1,726 1,606 Rest of world 3,566 2,004 $ 16,854 $ 11,309 Revenue by product group was (in thousands): Year ended December 31, 2021 2020 License and service contracts $ 14,164 $ 10,514 Subscription-based contracts 2,690 795 $ 16,854 $ 11,309 Revenue included by product group consists of all associated revenue within the contract, including license revenue, maintenance revenue, and services and other revenue. Revenue by product group may be recognized at a point in time or over-time. These revenues are attributable to both contracts with fixed fees or guaranteed minimums. Revenue by timing of transfer of goods or services was (in thousands): Year ended December 31, 2021 2020 Goods or services transferred at a point in time $ 7,992 $ 5,120 Goods or services transferred over time 8,862 6,189 $ 16,854 $ 11,309 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Schedule of Assets Measured at Fair Value on a Recurring Basis | As of December 31, 2021, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2021 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Assets: Money market funds (included in cash and cash equivalents) $ 28,952 $ - $ - Total assets $ 28,952 $ - $ - Liabilities: Contingent acquisition payment $ - $ - $ 919 Total liabilities $ - $ - $ 919 As of December 31, 2020, our assets that are measured at fair value on a recurring basis and whose carrying values approximate their respective fair values include the following (in thousands): Fair Value Measurement at December 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs (Level 1) (Level 2) (Level 3) Money market funds (included in cash and cash equivalents) $ 37,948 $ - $ - Total $ 37,948 $ - $ - |
Schedule of Allowance for Doubtful Accounts | For the years ended December 31, 2021 and 2020, changes to and ending balances of the allowance for doubtful accounts were as follows (in thousands): Years ended December 31, 2021 2020 Allowance for doubtful accounts balance - beginning of year $ 138 $ 20 Additions to the allowance for doubtful accounts - 118 Deductions against the allowance for doubtful accounts (64 ) - Allowance for doubtful accounts balance - end of year $ 74 $ 138 |
Schedule of Estimated Useful Lives Assets | The estimated useful lives of assets are: Building 30 years Building improvements 5 to 20 years Furniture and fixtures 5 years Computer and office equipment 3 years Purchased software 3 years |
Schedule of Goodwill | The changes in goodwill for the years ended December 31, 2021 and 2020 were as follows (in thousands): Goodwill Balance as of December 31, 2019 $ — Goodwill arising from AFIX acquisition 1,651 Balance as of December 31, 2020 1,651 Goodwill arising from FortressID acquisition 1,469 Balance as of December 31, 2021 $ 3,120 |
Schedule of Changes in Contract Assets and Liabilities | The following table presents changes in our contract assets and liabilities during the years ended December 31, 2021 and 2020 (in thousands): Balance at Beginning of period Revenue Recognized In Advance of Billings Billings Balance at End of Period Year ended December 31, 2020 Contract Assets: Unbilled receivables $ 3,315 $ 1,508 $ (2,594 ) $ 2,229 Year ended December 31, 2021 Contract Assets: Unbilled receivables $ 2,229 $ 7,172 $ (6,314 ) $ 3,087 Balance at Beginning of period Billings Revenue Recognized Balance at End of Period Year ended December 31, 2020 Contract Liabilities: Deferred revenue $ 2,837 $ 6,619 $ (5,523 ) $ 3,933 Year ended December 31, 2021 Contract Liabilities: Deferred revenue $ 3,933 $ 6,486 $ (6,679 ) $ 3,740 |
Schedules of Concentration of Credit Risk with Respect to Net Accounts Receivable and Total Revenue | 2021 2020 Customer A 27 % 39 % Customer B - 13 % |
Schedule of Revenues Generated from Geographic Regions | Revenues were generated from the following geographic regions (in thousands): Year ended December 31, 2021 2020 United States $ 9,624 $ 6,724 Brazil 1,938 975 United Kingdom 1,726 1,606 Rest of world 3,566 2,004 $ 16,854 $ 11,309 |
Schedule of Revenue by Product Group | Revenue by product group was (in thousands): Year ended December 31, 2021 2020 License and service contracts $ 14,164 $ 10,514 Subscription-based contracts 2,690 795 $ 16,854 $ 11,309 |
Schedule of Revenue by Timing of Transfer of Goods or Services | Revenue by timing of transfer of goods or services was (in thousands): Year ended December 31, 2021 2020 Goods or services transferred at a point in time $ 7,992 $ 5,120 Goods or services transferred over time 8,862 6,189 $ 16,854 $ 11,309 |
Property and Equipment (Tables)
Property and Equipment (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Property Plant And Equipment [Abstract] | |
Schedule of Property and Equipment | Property and equipment consisted of the following at December 31 (in thousands): 2021 2020 Land $ 1,056 $ 1,056 Building and improvements 9,166 9,166 Computer and office equipment 1,310 1,283 Purchased software 155 154 Furniture and fixtures 778 778 Total 12,465 12,437 Less accumulated depreciation (9,249 ) (8,736 ) Property and equipment, net $ 3,216 $ 3,701 |
Acquisitions (Tables)
Acquisitions (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Business Acquisition [Line Items] | |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | During the years ended December 31, 2021 and 2020 we recorded $176 thousand and $26 thousand of amortization expense on intangible assets, respectively. The Company expects to record amortization for the years ended December 31 as follows (in thousands): 2022 $ 415 2023 415 2024 415 2025 412 2026 412 Thereafter 1,153 $ 3,222 |
Fortress ID | |
Business Acquisition [Line Items] | |
Summary of Fair Value of Assets Acquired and Liabilities Assumed At Date of Acquisition | The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands): Customer relationships $ 1,740 Developed technology 430 Trade name / trademarks 10 Goodwill 1,469 Gross assets acquired 3,649 Net working capital (11 ) Fair value of contingent consideration (919 ) Net assets acquired $ 2,719 |
Summary of Fair Value of Intangible Assets and Estimated Useful Live | The fair value of intangible assets and their estimated useful live as of December 31, 2021 are as follows (dollars in thousands): Useful Life Gross Amount Accumulated Amortization Net Book Value Customer relationships 10 years $ 1,740 $ - $ 1,740 Developed technology 7 years 430 - 430 Trade name / trademarks 3 years 10 - 10 $ 2,180 $ - $ 2,180 |
Bill of Sale and Assignment Agreement | |
Business Acquisition [Line Items] | |
Summary of Fair Value of Assets Acquired and Liabilities Assumed At Date of Acquisition | The following table summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition (in thousands) : Net working capital, excluding deferred revenue $ 155 Customer relationships 940 Developed technology 280 Trade name / trademarks 20 Goodwill 1,651 Gross assets acquired 3,046 Deferred revenue (616 ) Net assets acquired $ 2,430 |
Summary of Fair Value of Intangible Assets and Estimated Useful Live | The fair value of intangible assets and their estimated useful live as of December 31, 2021are as follows (dollars in thousands): Useful Life Gross Amount Accumulated Amortization Net Book Value Customer relationships 8 years $ 940 $ 132 $ 808 Developed technology 5 years 280 63 217 Tradenames 7 years 20 3 17 $ 1,240 $ 198 $ 1,042 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of Components of Benefit from Income Taxes | The components of the benefit from income taxes are as follows (in thousands): Year ended December 31, 2021 2020 Current: Federal $ - $ (1,397 ) State — (237 ) — (1,634 ) Deferred: Federal (147 ) — State (122 ) — (269 ) — Benefit from income taxes $ (269 ) $ (1,634 ) |
Schedule of Reconciliation of U.S. Federal Statutory Rate to Effective Tax Rate | The 2021 difference between the effective tax rate and the U.S federal statutory rates was driven primarily due to the change in valuation allowance of our deferred tax assets. A reconciliation of the U.S. federal statutory rate to the effective tax rate is as follows: Year ended December 31, 2021 2020 Federal statutory rate 21 % 21 % State rate, net of federal benefit 6 6 Tax credits 2 3 Permanent adjustments — — Change in valuation allowance (24 ) (25 ) Expiration of statutes on uncertain tax positions — 2 Net operating loss carryback rate benefit under CARES Act — 11 Other (1 ) — Effective tax rate 4 % 18 % |
Schedule of Principal Components of Deferred Tax Assets | The principal components of deferred tax assets, net, were as follows at December 31 (in thousands): 2021 2020 Depreciation $ 367 $ 307 Stock-based compensation 405 121 Research and development credits 6,904 6,686 Net operating loss 3,380 1,352 Other 254 208 Total deferred tax assts 11,310 8,674 Valuation allowance (10,730 ) (8,674 ) Deferred tax liabilities Intangibles (580 ) — Total deferred tax liabilities (580 ) — Net deferred tax assets (liabilities) $ - $ - |
Schedule of Roll forward of Uncertain Tax Position Related to Research and Development Tax Credits | A roll forward of the uncertain tax position that was primarily related to our research and development tax credits is as follows (in thousands): Uncertain tax positions at December 31, 2019 $ 1,008 Increase due to positions taken in prior periods (206 ) Uncertain tax positions at December 31, 2020 802 Decrease due to positions taken in prior periods — Uncertain tax positions at December 31, 2021 $ 802 |
Equity and Stock Compensation_2
Equity and Stock Compensation Plans (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
Schedule of Stock-based Employee Compensation Expenses Included in Consolidated Statements of Income and Comprehensive Income | The following table presents stock-based compensation expenses included in our consolidated statements of operations (in thousands): Years ended December 31, 2021 2020 Cost of services $ 23 $ 17 Research and development 261 188 Selling and marketing 250 168 General and administrative 1,033 465 Stock-based compensation expense $ 1,567 $ 838 |
Schedule of Specific Assumptions Used to Determine the Fair Value of Options Granted Using the Black Scholes Valuation Model | Specific assumptions used to determine the fair value of options granted during the years ended December 31, 2021 and 2020, using the Black-Scholes valuation model were as follows: Years ended December 31, 2021 2020 Expected term (1) 6.26 years 6.14 years Expected volatility factor (2) 39 % 37 % Risk-free interest rate (3) 0.6 % 0.6 % Expected annual dividend yield n/a n/a (1) The expected term for each grant was determined based on the simplified method. (2) The expected volatility for each grant is estimated based on an average of historical volatility over the expected term of the stock options. (3) The risk-free interest rate for each grant is based on the U.S. Treasury yield curve in effect at the time of grant for a period equal to the expected term of the stock option. |
Summary of Stock Option Transactions for Fixed Stock Option Plan | 2021 2020 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Outstanding at beginning of year 425,000 $ 6.00 435,000 $ 6.00 Granted 2,875,000 $ 4.73 50,000 $ 6.00 Exercised — — — — Forfeited or cancelled 60,000 $ 4.73 60,000 $ 6.00 Outstanding at end of year 3,240,000 $ 4.97 425,000 $ 6.00 Exercisable at year end 218,748 $ 6.00 112,496 $ 6.00 |
Summary of Stock Options Outstanding | The following table summarizes the stock options outstanding at December 31, 2021: Options Outstanding Options Exercisable Exercise Price Range Number Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in years) Number Weighted Average Exercise Price $4 to $5 2,921,250 $ 4.72 9.11 54,687 $ 4.50 $5 to $6 106,250 $ 5.50 7.83 54,687 $ 5.50 $6 to $7 106,250 $ 6.50 7.83 54,687 $ 6.50 $7 to $8 106,250 $ 7.50 7.83 54,687 $ 7.50 3,240,000 $ 4.97 9.00 218,748 $ 6.00 |
Net Loss Per Share (Tables)
Net Loss Per Share (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Earnings Per Share [Abstract] | |
Summary of Potentially Outstanding Common Shares Anti-dilutive | The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive (in thousands): Year ended December 31, 2021 2020 Stock options 2,823 433 |
Schedule of Net Loss Per Share | Net loss per share is calculated as follows (in thousands, except per share data): Year ended December 31, 2021 2020 Net loss (5,824 ) (7,614 ) Shares outstanding: Weighted-average common shares outstanding 21,525 21,473 Additional dilutive common stock equivalents — — Diluted shares outstanding 21,525 21,473 Net loss per share – basic $ (0.27 ) $ (0.35 ) Net loss per share - diluted $ (0.27 ) $ (0.35 ) |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Fair Value Measurements, Goodwill, Valuation of Long-Lived Assets, Revenue Recognition (Details) - USD ($) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Significant Of Accounting Policies [Line Items] | |||
Cash and cash equivalents | $ 29,963,000 | $ 38,565,000 | $ 47,742,000 |
Goodwill impairment | 0 | ||
Goodwill | 3,120,000 | 1,651,000 | |
Impairment loss | $ 0 | ||
Practical expedient for financing components | true | ||
Minimum period of payment of transaction price in contract with customer | 30 days | ||
Maximum period of payment of transaction price in contract with customer | 60 days | ||
Minimum | |||
Disclosure Of Significant Of Accounting Policies [Line Items] | |||
Percentage of likelihood for goodwill examination of quantitative test | 50.00% | ||
Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) | Money market funds (included in cash and cash equivalents) | |||
Disclosure Of Significant Of Accounting Policies [Line Items] | |||
Cash equivalents, primarily include money market funds | $ 29,000,000 | $ 37,900,000 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Assets Measured at Fair Value on a Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets: | ||
Total assets | $ 28,952 | $ 37,948 |
Liabilities: | ||
Contingent acquisition payment | 0 | |
Total liabilities | 0 | |
Significant Other Observable Inputs (Level 2) | ||
Assets: | ||
Total assets | 0 | 0 |
Liabilities: | ||
Contingent acquisition payment | 0 | |
Total liabilities | 0 | |
Significant Unobservable Inputs (Level 3) | ||
Assets: | ||
Total assets | 0 | 0 |
Liabilities: | ||
Contingent acquisition payment | 919 | |
Total liabilities | 919 | |
Money market funds (included in cash and cash equivalents) | Quoted Prices in Active Markets for Identical Assets (Level 1) | ||
Assets: | ||
Money market funds (included in cash and cash equivalents) | 28,952 | 37,948 |
Money market funds (included in cash and cash equivalents) | Significant Other Observable Inputs (Level 2) | ||
Assets: | ||
Money market funds (included in cash and cash equivalents) | 0 | 0 |
Money market funds (included in cash and cash equivalents) | Significant Unobservable Inputs (Level 3) | ||
Assets: | ||
Money market funds (included in cash and cash equivalents) | $ 0 | $ 0 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Allowance for Doubtful Accounts Receivable | ||
Allowance for doubtful accounts balance - beginning of year | $ 138 | $ 20 |
Additions to the allowance for doubtful accounts | 118 | |
Deductions against the allowance for doubtful accounts | (64) | 0 |
Allowance for doubtful accounts balance - end of year | $ 74 | $ 138 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) | 12 Months Ended |
Dec. 31, 2021 | |
Building | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 30 years |
Building improvements | Minimum | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 5 years |
Building improvements | Maximum | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 20 years |
Furniture and Fixtures | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 5 years |
Computer and office equipment | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 3 years |
Purchased software | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | |
Estimated useful lives of assets | 3 years |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||
Beginning Balance | $ 1,651 | |
Ending Balance | 3,120 | $ 1,651 |
AFIX | ||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||
Goodwill | $ 1,651 | |
Fortress ID | ||
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||
Goodwill | 1,469 | |
Ending Balance | $ 1,469 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies - Contract Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Unbilled receivables, Balance at Beginning of Period | $ 2,229 | $ 3,315 |
Unbilled receivables, Revenue Recognized In Advance of Billings | 7,172 | 1,508 |
Unbilled receivables, Billings | (6,314) | (2,594) |
Unbilled receivables, Balance at End of Period | $ 3,087 | $ 2,229 |
Summary of Significant Accou_10
Summary of Significant Accounting Policies - Contract Liabilities (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Deferred revenue, Balance at Beginning of Period | $ 3,933 | $ 2,837 |
Deferred revenue, Billings | 6,486 | 6,619 |
Deferred revenue, Revenue Recognized | (6,679) | (5,523) |
Deferred revenue, Balance at End of Period | $ 3,740 | $ 3,933 |
Summary of Significant Accou_11
Summary of Significant Accounting Policies - Remaining Performance Obligation , Contract Costs , Capitalization Costs and Concentration of Credit Risk (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Percentage of remaining performance obligations expected to be recognized as revenue | 67.00% | |
Minimum period of remaining performance obligations | 12 months | |
Revenue recognition performance obligation transaction price | $ 2,600,000 | |
Revenue, Practical Expedient, Incremental Cost of Obtaining Contract [true false] | true | |
Software costs capitalized during period | $ 0 | $ 0 |
Cash and cash equivalents, in excess of federally insured deposit limits | $ 29,700,000 | $ 38,300,000 |
Percentage of accounts receivable and unbilled receivables owned by customers | 10.00% |
Summary of Significant Accou_12
Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Accounts Receivable [Member] - Credit Concentration Risk [Member] | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Customer A [Member] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Concentration risk, percentage | 27.00% | 39.00% |
Customer B [Member] | ||
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | ||
Concentration risk, percentage | 13.00% |
Summary of Significant Accou_13
Summary of Significant Accounting Policies - Revenues Generated Following Geographic Regions (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 16,854 | $ 11,309 |
Operating Segments | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 16,854 | 11,309 |
Operating Segments | United States | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 9,624 | 6,724 |
Operating Segments | United Kingdom | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 1,726 | 1,606 |
Operating Segments | Brazil | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 1,938 | 975 |
Operating Segments | Rest of World | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 3,566 | $ 2,004 |
Summary of Significant Accou_14
Summary of Significant Accounting Policies - Summary of Revenue by Product Group (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 16,854 | $ 11,309 |
License and Service Contracts | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 7,973 | 5,038 |
Operating Segments | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 16,854 | 11,309 |
Operating Segments | License and Service Contracts | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 14,164 | 10,514 |
Operating Segments | Subscription-based Contracts | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 2,690 | $ 795 |
Summary of Significant Accou_15
Summary of Significant Accounting Policies - Revenue by Timing of Transfer of Goods or Services (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 16,854 | $ 11,309 |
Goods or services transferred at a point in time | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | 7,992 | 5,120 |
Goods or services transferred over time | ||
Disaggregation of Revenue [Line Items] | ||
Total revenue | $ 8,862 | $ 6,189 |
Property and Equipment - Summar
Property and Equipment - Summary of Property and Equipment (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Property and Equipment | ||
Total | $ 12,465 | $ 12,437 |
Less accumulated depreciation | (9,249) | (8,736) |
Property and equipment, net | 3,216 | 3,701 |
Land | ||
Property and Equipment | ||
Total | 1,056 | 1,056 |
Building and Improvements | ||
Property and Equipment | ||
Total | 9,166 | 9,166 |
Computer and Office Equipment | ||
Property and Equipment | ||
Total | 1,310 | 1,283 |
Purchased software | ||
Property and Equipment | ||
Total | 155 | 154 |
Furniture and Fixtures | ||
Property and Equipment | ||
Total | $ 778 | $ 778 |
Property and Equipment (Details
Property and Equipment (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Property Plant And Equipment [Abstract] | ||
Depreciation expense | $ 0.5 | $ 0.5 |
Acquisitions - Additional Infor
Acquisitions - Additional Information (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |||
Nov. 30, 2020 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2023 | Dec. 31, 2022 | |
Business Acquisition [Line Items] | |||||
Business acquisition, purchase price | $ 2,450,000 | $ 2,430,000 | |||
Goodwill | 3,120,000 | 1,651,000 | |||
Goodwill related to deferred tax assets | (580,000) | ||||
Maximum | |||||
Business Acquisition [Line Items] | |||||
Contingent consideration earn out payable | $ 4,000,000 | ||||
Maximum | Scenario Forecast | |||||
Business Acquisition [Line Items] | |||||
Earn out cash payments | $ 2,000,000 | $ 2,000,000 | |||
Fortress ID | |||||
Business Acquisition [Line Items] | |||||
Percentage of ownership control | 100.00% | ||||
Business acquisition, purchase price | $ 3,400,000 | ||||
Business acquisition, cash consideration | 2,500,000 | ||||
Business acquisition, earnout with fair value | 900,000 | ||||
Goodwill | 1,469,000 | ||||
Goodwill related to deferred tax assets | $ 300,000 | ||||
Bill of Sale and Assignment Agreement | |||||
Business Acquisition [Line Items] | |||||
Goodwill | $ 1,651,000 | ||||
Cash consideration to acquire business | $ 2,400,000 | ||||
Business acquisition date of agreement | Nov. 30, 2020 | ||||
Amortization expense on intangible assets | $ 176,000 | $ 26,000 |
Acquisitions - Summary of Fair
Acquisitions - Summary of Fair Value of Assets Acquired and Liabilities Assumed At Date of Acquisition (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 | Nov. 30, 2020 |
Business Acquisition [Line Items] | |||
Goodwill | $ 3,120 | $ 1,651 | |
Fortress ID | |||
Business Acquisition [Line Items] | |||
Goodwill | 1,469 | ||
Gross assets acquired | 3,649 | ||
Net working capital | (11) | ||
Fair value of contingent consideration | (919) | ||
Net assets acquired | 2,719 | ||
Bill of Sale and Assignment Agreement | |||
Business Acquisition [Line Items] | |||
Goodwill | $ 1,651 | ||
Gross assets acquired | 3,046 | ||
Net working capital | 155 | ||
Deferred revenue | (616) | ||
Net assets acquired | 2,430 | ||
Customer Relationships | Fortress ID | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | 1,740 | ||
Customer Relationships | Bill of Sale and Assignment Agreement | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | 940 | ||
Developed Technology | Fortress ID | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | 430 | ||
Developed Technology | Bill of Sale and Assignment Agreement | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | 280 | ||
Trade Name / Trademarks | Fortress ID | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | $ 10 | ||
Trade Name / Trademarks | Bill of Sale and Assignment Agreement | |||
Business Acquisition [Line Items] | |||
Intangible assets acquired | $ 20 |
Acquisitions - Summary of Fai_2
Acquisitions - Summary of Fair Value of Intangible Assets and Estimated Useful Live (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Net Book Value | $ 3,222 |
Fortress ID | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Gross Amount | 2,180 |
Net Book Value | 2,180 |
Bill of Sale and Assignment Agreement | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Gross Amount | 1,240 |
Accumulated Amortization | 198 |
Net Book Value | $ 1,042 |
Customer Relationships | Fortress ID | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 10 years |
Gross Amount | $ 1,740 |
Net Book Value | $ 1,740 |
Customer Relationships | Bill of Sale and Assignment Agreement | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 8 years |
Gross Amount | $ 940 |
Accumulated Amortization | 132 |
Net Book Value | $ 808 |
Developed Technology | Fortress ID | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 7 years |
Gross Amount | $ 430 |
Net Book Value | $ 430 |
Developed Technology | Bill of Sale and Assignment Agreement | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 5 years |
Gross Amount | $ 280 |
Accumulated Amortization | 63 |
Net Book Value | $ 217 |
Trade Name / Trademarks | Fortress ID | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 3 years |
Gross Amount | $ 10 |
Net Book Value | $ 10 |
Tradenames | Bill of Sale and Assignment Agreement | |
Acquired Finite Lived Intangible Assets [Line Items] | |
Estimated useful live | 7 years |
Gross Amount | $ 20 |
Accumulated Amortization | 3 |
Net Book Value | $ 17 |
Acquisitions - Schedule of Fini
Acquisitions - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands | Dec. 31, 2021USD ($) |
Finite Lived Intangible Assets Net Amortization Expense Rolling Maturity [Abstract] | |
2022 | $ 415 |
2023 | 415 |
2024 | 415 |
2025 | 412 |
2026 | 412 |
Thereafter | 1,153 |
Net Book Value | $ 3,222 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Line Items] | ||
Income tax expense (Benefit) | $ (269) | $ (1,634) |
Deferred tax assets | 10,700 | 8,700 |
Research and development credits | 6,904 | 6,686 |
Pre Tax Gain (Loss) | (6,100) | |
Net operating loss carryforward | 16,700 | |
Valuation allowance | 10,730 | 8,674 |
Increase in deferred tax assets valuation allowance | 2,000 | |
Uncertain tax positions | 800 | |
Fortress ID | ||
Income Tax Disclosure [Line Items] | ||
Net operating loss carryforward | 3,500 | |
Federal | ||
Income Tax Disclosure [Line Items] | ||
Net operating loss carryforward | $ 7,300 | |
CARES Act | ||
Income Tax Disclosure [Line Items] | ||
Income tax expense (Benefit) | $ 1,400 |
Income Taxes - Schedule of Comp
Income Taxes - Schedule of Components of Benefit from Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Current: | ||
Federal | $ (1,397) | |
State | (237) | |
Total current tax | (1,634) | |
Deferred: | ||
Federal | $ (147) | |
State | (122) | |
Total deferred tax | (269) | |
Benefit from income taxes | $ (269) | $ (1,634) |
Income Taxes - Schedule of Reco
Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Rate to Effective Tax Rate (Details) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||
Federal statutory rate | 21.00% | 21.00% |
State rate, net of federal benefit | 6.00% | 6.00% |
Tax credits | 2.00% | 3.00% |
Change in valuation allowance | (24.00%) | (25.00%) |
Expiration of statutes on uncertain tax positions | 2.00% | |
Net operating loss carryback rate benefit under CARES Act | 11.00% | |
Other | (1.00%) | |
Effective tax rate | 4.00% | 18.00% |
Income Taxes - Schedule of Prin
Income Taxes - Schedule of Principal Components of Deferred Tax Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | ||
Depreciation | $ 367 | $ 307 |
Stock-based compensation | 405 | 121 |
Research and development credits | 6,904 | 6,686 |
Net operating loss | 3,380 | 1,352 |
Other | 254 | 208 |
Total deferred tax assts | 11,310 | 8,674 |
Valuation allowance | (10,730) | $ (8,674) |
Intangibles | (580) | |
Total deferred tax liabilities | $ (580) |
Income Taxes - Schedule of Roll
Income Taxes - Schedule of Roll forward of Uncertain Tax Position Related to Research and Development Tax Credits (Details) - Research Tax Credit Carryforward [Member] - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Tax Credit Carryforward [Line Items] | ||
Uncertain tax positions at December 31 | $ 802 | $ 1,008 |
Increase due to positions taken in prior periods | (206) | |
Decrease due to positions taken in prior periods | 0 | |
Uncertain tax positions at December 31 | $ 802 | $ 802 |
Equity and Stock Compensation_3
Equity and Stock Compensation Plans - Stock Option Plan (Details) - 2001 Nonqualified Stock Plan | 12 Months Ended |
Dec. 31, 2021shares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Number of stock awards authorized to grant | 8,000,000 |
Number of stock awards available for grant | 889,262 |
Minimum | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Term of options vested | 3 years |
Maximum | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
Term of options granted at exercise prices | 10 years |
Term of options vested | 5 years |
Equity and Stock Compensation_4
Equity and Stock Compensation Plans - Summary of Stock-based Compensation Expenses (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | $ 1,567 | $ 838 |
Cost of services | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | 23 | 17 |
Research and development | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | 261 | 188 |
Selling and marketing | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | 250 | 168 |
General and administrative | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Total stock-based compensation expense | $ 1,033 | $ 465 |
Equity and Stock Compensation_5
Equity and Stock Compensation Plans - Stock Option Grants and Unrestricted Stock Grants (Details) | 1 Months Ended | 2 Months Ended | 6 Months Ended | 12 Months Ended | |||||
May 31, 2020shares | Mar. 31, 2020shares | Oct. 31, 2019shares | Sep. 30, 2019shares | Nov. 30, 2020shares | Dec. 31, 2020installment$ / sharesshares | Dec. 31, 2021USD ($)installment$ / sharesshares | Dec. 31, 2020USD ($)$ / sharesshares | Dec. 31, 2019USD ($)installment$ / sharesshares | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Total stock-based compensation expense | $ 1,567,000 | $ 838,000 | |||||||
Stock options | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of stock options granted | shares | 2,875,000 | 50,000 | |||||||
Number of options outstanding | shares | 3,240,000 | ||||||||
Number of shares vested | shares | 218,748 | ||||||||
Weighted average exercise price of options outstanding | $ / shares | $ 6 | ||||||||
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 9 years | ||||||||
Weighted average remaining contractual term | 7 years 11 months 1 day | ||||||||
Aggregate intrinsic value of options outstanding | $ 0 | ||||||||
Aggregate intrinsic value of options exercisable | 0 | ||||||||
Unrestricted Stock | 2020 Grant | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Unamortized share-based compensation charges | $ 0 | ||||||||
Unrestricted Stock | 2019 Grant | Directors, officers and employees | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of installment | installment | 4 | ||||||||
Total stock-based compensation expense | $ 400,000 | ||||||||
Number of unrestricted stock granted | shares | 120,000 | 120,000 | 120,000 | ||||||
Stock-based compensation expense charged to expense | 84,000 | $ 84,000 | $ 23,000 | ||||||
Remaining stock based compensation expense | $ 145,000 | ||||||||
Unrestricted Stock | 2001 Nonqualified Stock Plan | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of shares granted (in shares) | shares | 56,553 | 256,250 | |||||||
Total stock-based compensation expense | $ 300,000 | ||||||||
Unamortized share-based compensation charges | $ 0 | ||||||||
Unrestricted Stock | 2001 Nonqualified Stock Plan | 2020 Grant | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of shares granted (in shares) | shares | 13,250 | ||||||||
Unrestricted Stock | 2001 Nonqualified Stock Plan | 2020 Grant | Director | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of shares granted (in shares) | shares | 56,553 | ||||||||
Number of installment | installment | 2 | ||||||||
Unrestricted Stock | 2001 Nonqualified Stock Plan | 2020 Grant | Directors, officers and employees | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of shares granted (in shares) | shares | 243,000 | 243,000 | 256,250 | ||||||
Number of installment | installment | 2 | ||||||||
Total stock-based compensation expense | $ 700,000 | ||||||||
Equity Option | |||||||||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||||||||
Number of stock options granted | shares | 2,875,000 | 50,000 | |||||||
Number of options outstanding | shares | 425,000 | 3,240,000 | 425,000 | 435,000 | |||||
Weighted average exercise price of options outstanding | $ / shares | $ 6 | $ 4.97 | $ 6 | $ 6 | |||||
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 9 years | ||||||||
Amount of unrecognized compensation expense related to non-vested options | $ 4,200,000 | ||||||||
Weighted average period for nonvested options | 3 years |
Equity and Stock Compensation_6
Equity and Stock Compensation Plans - Assumptions to Determine Fair Value of Options (Details) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||
Expected term | 6 years 3 months 3 days | 6 years 1 month 20 days |
Expected volatility factor | 39.00% | 37.00% |
Risk-free interest rate | 0.60% | 0.60% |
Equity and Stock Compensation_7
Equity and Stock Compensation Plans - Summary of Stock Option Transactions (Details) - Stock Option [Member] - $ / shares | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Shares | ||
Outstanding at beginning of year | 425,000 | 435,000 |
Number of stock options granted | 2,875,000 | 50,000 |
Forfeited or cancelled | 60,000 | 60,000 |
Outstanding at end of year | 3,240,000 | 425,000 |
Exercisable at year end | 218,748 | 112,496 |
Weighted Average Exercise Price | ||
Outstanding at beginning of year | $ 6 | $ 6 |
Granted | 4.73 | 6 |
Forfeited or cancelled | 4.73 | 6 |
Outstanding at end of year | 4.97 | 6 |
Exercisable at year end | $ 6 | $ 6 |
Equity and Stock Compensation_8
Equity and Stock Compensation Plans - Summarizes of Stock Options Outstanding (Details) - $ / shares | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Exercise price range $4 to $5 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Options outstanding, Number | 2,921,250 | ||
Options exercisable, Number | 54,687 | ||
Options outstanding, Weighted average remaining contractual term (in years) | 9 years 1 month 9 days | ||
Options outstanding, Weighted average exercise price | $ 4.72 | ||
Options exercisable, Weighted average exercise price | $ 4.50 | ||
Exercise price range $5 to $6 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Options outstanding, Number | 106,250 | ||
Options exercisable, Number | 54,687 | ||
Options outstanding, Weighted average remaining contractual term (in years) | 7 years 9 months 29 days | ||
Options outstanding, Weighted average exercise price | $ 5.50 | ||
Options exercisable, Weighted average exercise price | $ 5.50 | ||
Exercise price range $6 to $7 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Options outstanding, Number | 106,250 | ||
Options exercisable, Number | 54,687 | ||
Options outstanding, Weighted average remaining contractual term (in years) | 7 years 9 months 29 days | ||
Options outstanding, Weighted average exercise price | $ 6.50 | ||
Options exercisable, Weighted average exercise price | $ 6.50 | ||
Exercise price range $7 to $8 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Options outstanding, Number | 106,250 | ||
Options exercisable, Number | 54,687 | ||
Options outstanding, Weighted average remaining contractual term (in years) | 7 years 9 months 29 days | ||
Options outstanding, Weighted average exercise price | $ 7.50 | ||
Options exercisable, Weighted average exercise price | $ 7.50 | ||
Stock Option [Member] | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Options outstanding, Number | 3,240,000 | 425,000 | 435,000 |
Options exercisable, Number | 218,748 | 112,496 | |
Options outstanding, Weighted average remaining contractual term (in years) | 9 years | ||
Options outstanding, Weighted average exercise price | $ 4.97 | $ 6 | $ 6 |
Options exercisable, Weighted average exercise price | 6 | $ 6 | |
Stock Option [Member] | Exercise price range $4 to $5 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Exercise price range (lower) | 4 | ||
Exercise price range (upper) | 5 | ||
Stock Option [Member] | Exercise price range $5 to $6 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Exercise price range (lower) | 5 | ||
Exercise price range (upper) | 6 | ||
Stock Option [Member] | Exercise price range $6 to $7 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Exercise price range (lower) | 6 | ||
Exercise price range (upper) | 7 | ||
Stock Option [Member] | Exercise price range $7 to $8 | |||
EQUITY AND STOCK COMPENSATION PLANS | |||
Exercise price range (lower) | 7 | ||
Exercise price range (upper) | $ 8 |
Equity and Stock Compensation_9
Equity and Stock Compensation Plans - Employee Stock Purchase Plan (Details) - USD ($) | 1 Months Ended | 12 Months Ended | |
May 31, 2021 | Dec. 31, 2021 | Dec. 31, 2020 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 1,567,000 | $ 838,000 | |
2021 ESPP Plan [Member] | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Percentage of common stock at a price lower of the fair market value | 85.00% | ||
Period of common stock offering | 6 months | ||
Total stock-based compensation expense | 100,000 | ||
Annual purchase limit | $ 25,000 | ||
Total number of common stock shares reserved for issuance | 1,000,000 | ||
Number of common stock shares reserved for issuance | 945,501 | ||
Issuance of common stock under employee stock purchase plan (in shares) | 54,499 | ||
1996 ESPP Plan [Member] | |||
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Issuance of common stock under employee stock purchase plan (in shares) | 6,972 | 15,388 |
Equity and Stock Compensatio_10
Equity and Stock Compensation Plans - Share Purchases (Details) - Share Purchases - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Apr. 30, 2020 | |
Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
Number of common stock authorized for repurchase | $ 10 | ||
Amount utilized under the program | $ 1 | ||
Number of stock repurchased | 0 | 298,214 |
Employee Benefit Plans (Details
Employee Benefit Plans (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Retirement Plans 401 K Defined Benefit | ||
Defined Contribution Plan Disclosure [Line Items] | ||
Discretionary contribution by employer | $ 0.4 | $ 0.3 |
Net Loss Per Share - Summary of
Net Loss Per Share - Summary of Potentially Outstanding Common Shares Anti-dilutive (Details) - shares shares in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Stock Options | ||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 2,823 | 433 |
Net Loss Per Share - Schedule o
Net Loss Per Share - Schedule of Net loss per share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Earnings Per Share [Abstract] | ||
Net loss | $ (5,824) | $ (7,614) |
Shares outstanding: | ||
Weighted-average common shares outstanding (in shares) | 21,525 | 21,473 |
Additional dilutive common stock equivalents (in shares) | 0 | 0 |
Diluted shares outstanding (in shares) | 21,525 | 21,473 |
Net loss per share – basic | $ (0.27) | $ (0.35) |
Net loss per share – diluted | $ (0.27) | $ (0.35) |
Potential Sale of Building - Ad
Potential Sale of Building - Additional Information (Details) - Purchase and Sale Agreement - FDS Bedford, LLC | Apr. 26, 2021USD ($) |
Potential Sale Of Building [Line Items] | |
Purchase obligation | $ 8,875,000 |
Purchaser obligated deposit | $ 125,000 |
Property occupy period | 6 months |
Subsequent Events - Additional
Subsequent Events - Additional information (Details) $ / shares in Units, $ in Millions | Mar. 11, 2022USD ($)$ / shares | Mar. 01, 2022USD ($)ft² | Dec. 31, 2021 |
Subsequent Event [Line Items] | |||
Lease, existence of option to terminate | true | ||
Lease, option to terminate | one-time termination right after seven years and six months | ||
Lease, existence of option to extend | true | ||
Lease, option to extend | a renewal option for up to two additional terms | ||
Subsequent Events | |||
Subsequent Event [Line Items] | |||
Rentable area | ft² | 20,730 | ||
Lease, term of contract | 10 years 6 months | ||
Rent expenses | $ 8.2 | ||
Lease, renewal term | 5 years | ||
Subsequent Events | Convertible Note | Omlis Limited | |||
Subsequent Event [Line Items] | |||
Convertible Note amount | $ 2.5 | ||
Interest rate percentage | 5.00% | ||
Maturity date | Mar. 11, 2026 | ||
Discount from effective price per share paid by investors, percentage | 20.00% | ||
Sale of note, description | Omlis granted us a right of first refusal for 18 months with respect to any proposed sale by Omlis of equity securities constituting 20% or more of the outstanding voting power of Omlis or all or substantially all of the assets of Omlis or any of its material subsidiaries. | ||
Warrants expire date | Sep. 11, 2023 | ||
Equity shares purchase price per shares | $ / shares | $ 33.91 | ||
Subsequent Events | Convertible Note | Omlis Limited | Maximum | |||
Subsequent Event [Line Items] | |||
Issuance of warrants purchase percentage | 8.00% |